Search Within

DOPAMINE
Results 1 - 707 of 707
Improvement of Learning and Increase in Dopamine Level in the Frontal Cortex by Methylphenidate in Mice Lacking Dopamine Transporter

Journal: Current Molecular Medicine
Volume: 15,Issue: 3
Page: 245-252
Authors: Y. Takamatsu, Y. Hagino, A. Sato, T. Takahashi, S.Y. Nagasawa, Y. Kubo, M. Mizuguchi, G.R. Uhl, I. Sora and K. Ikeda

Dopamine Receptor Interacting Proteins: Targeting Neuronal Calcium Sensor-1/D2 Dopamine Receptor Interaction for Antipsychotic Drug Development

Journal: Current Drug Targets
Volume: 13,Issue: 1
Page: 72-79
Authors: Nadine Kabbani, Mathew P. Woll, Jacob C. Nordman and Robert Levenson

Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 91-95
Authors: Y. Hagino, Y. Takamatsu, H. Yamamoto, T. Iwamura, D. L. Murphy, G. R. Uhl, I. Sora and K. Ikeda

Partial Dopamine Agonists and the Treatment of Psychosis

Journal: Current Neuropharmacology
Volume: 3,Issue: 1
Page: 3-8
Authors: Carol A. Tamminga

Dopamine Receptor and Hypertension

Journal: Current Medicinal Chemistry-Cardiovascular & Hematological Agents
Volume: 3,Issue: 1
Page: 69-77
Authors: Chunyu Zeng, Gilbert M. Eisner, Robin A. Felder and Pedro A. Jose

Phasic Dopamine Release in Appetitive Behaviors and Drug Addiction

Journal: Current Drug Abuse Reviews
Volume: 2,Issue: 2
Page: 195-213
Authors: Matthew J. Wanat, Ingo Willuhn, Jeremy J. Clark and Paul E.M. Phillips

Schizophrenia: From Dopamine to Glutamate and Back

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 3
Page: 267-277
Authors: M. L. Carlsson, A. Carlsson and M. Nilsson

Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 1,Issue: 2
Page: 141-147
Authors: C. A. Tamminga and A. Carlsson

Evidence that Cortical Dopamine is a Co-Transmitter in Noradrenergic Neurons

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 1
Page: 103-109
Authors: Paola Devoto and Giovanna Flore

Excitability of Dopamine Neurons: Modulation and Physiological Consequences

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 79-97
Authors: F. J. White, X- T. Hu, M. Marinelli and C. N. Rudick

Antidepressants Alter Mesostriatal Dopamine Interactions with Serotonin Signaling

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 4
Page: 453-461
Authors: Fu-Ming Zhou and John A. Dani

Differentiation of Non-Pharmacological from Pharmacological Dopamine Release in the Living Human Brain

Journal: Current Medical Imaging Reviews
Volume: 7,Issue: 2
Page: 104-106
Authors: Xingdang Liu, James Robert Brasic and Yun Zhou

Dopamine and Vascular Dynamics Control: Present Status and Future Perspectives

Journal: Current Neurovascular Research
Volume: 8,Issue: 3
Page: 246-257
Authors: Seyed Khosrow Tayebati, Mustafa F. Lokhandwala and Francesco Amenta

Dopamine Administration in Very Low Birth Weight Preterm Infants:Emerging Issues on Endocrine Effects

Journal: Current Pediatric Reviews
Volume: 3,Issue: 2
Page: 141-166
Authors: Luca Filippi, Chiara Poggi and Marco Pezzati

Dopamine Agonists in the Treatment of Parkinsons Disease-Past, Present and Future

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 12
Page: 1211-1248
Authors: S. Y. Sit

Development of Neurochemical Normalization (“Agonist Substitution”) Therapeutics for Stimulant Abuse: Focus on the Dopamine Uptake Inhibitor, GBR12909

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 4,Issue: 1
Page: 47-59
Authors: Thomas Prisinzano, Kenner C. Rice, Michael H. Baumann and Richard B. Rothman

Neuroplasticity within the Mesoaccumbens Dopamine System and its Role in Tobacco Dependence

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 1,Issue: 4
Page: 413-421
Authors: David J.K. Balfour

Three-Dimensional Pharmacophore Mapping of a Series of Isoxazolylpiperazine Inhibitors Selectively Acting on the Dopamine D4 Receptor

Journal: Letters in Drug Design & Discovery
Volume: 1,Issue: 4
Page: 372-379
Authors: In Young Lee, Yeon Joo Lee, Yong Seo Cho, Ae Nim Pae and Hun Yeong Koh

Dopamine Receptor Pharmacology: Interactions with Serotonin Receptors and Significance for the Aetiology and Treatment of Schizophrenia

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 3-23
Authors: J. C. Glennon, W. J. Wadman, A. C. McCreary and T. R. Werkman

Phasic Dopamine Signaling During Behavior, Reward, and Disease States

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 99-108
Authors: R. M. Wightman and M. L.A.V. Heien

Markers Associated with Sex Differences in Methamphetamine-Induced Striatal Dopamine Neurotoxicity

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 40-44
Authors: D. E. Dluzen, J. L. McDermott, M. Bourque, T. Di Paolo, A. S. Darvesh, A. B. Buletko and N. J. Laping

Allosteric Modulation of Dopamine Receptors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 5,Issue: 6
Page: 555-561
Authors: John A. Schetz

Estradiol, Dopamine and Motivation

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 83-89
Authors: Katie E. Yoest, Jennifer A. Cummings and Jill B. Becker

Subtype-Selective Dopamine Receptor Radioligands for PET Imaging: Current Status and Recent Developments

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 23
Page: 3957-3966
Authors: A. Banerjee and O. Prante

A New Approach for Treatment of Hypertension: Modifying D1 Dopamine Receptor Function

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 4,Issue: 4
Page: 369-377
Authors: Chunyu Zeng, Robin A. Felder and Pedro A. Jose

Regulation of Blood Pressure by D5 Dopamine Receptors

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5,Issue: 3
Page: 241-248
Authors: Chunyu Zeng, Zhiwei Yang, Laureano D. Asico and Pedro A. Jose

Dopamine Receptor Agonists for Protection and Repair in Parkinsons Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 8,Issue: 12
Page: 1089-1099
Authors: Giulia Ferrari-Toninelli, Sara A. Bonini, Giovanna Cenini, Giuseppina Maccarinelli, Mariagrazia Grilli, Daniela Uberti and Maurizio Memo

The Dopamine D2 and Adenosine A2A Receptors: Past, Present and Future Trends for the Treatment of Parkinson's Disease

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 27
Page: 3188-3210
Authors: M. Jorg, P.J. Scammells and B. Capuano

Advances in the Electrochemical Analysis of Dopamine

Journal: Current Analytical Chemistry
Volume: 13,Issue: 2
Page: 89-103
Authors: Margarita Stoytcheva, Roumen Zlatev, Zdravka Velkova, Velizar Gochev, Gisela Montero, Lydia Toscano and Amelia Olivas

Dopamine and the Diseased Brain

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 109-131
Authors: T. Kienast and A. Heinz

Relevance of Dopamine D2/Neurotensin NTS1 and NMDA/Neurotensin NTS1 Receptor Interaction in Psychiatric and Neurodegenerative Disorders

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 3
Page: 304-316
Authors: S. Tanganelli, T. Antonelli, M. C. Tomasini, S. Beggiato, K. Fuxe and L. Ferraro

Plausible Improvements for Selective Targeting of Dopamine Receptors in Therapy of Parkinson’s Disease

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12,Issue: 14
Page: 1556-1564
Authors: Pratibha Mehta Luthra and J.B. Senthil Kumar

Modulation of T-cell Mediated Immunity by Dopamine Receptor D5

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 13,Issue: 2
Page: 184-194
Authors: Carolina Prado, Sebastian Bernales and Rodrigo Pacheco

Partial Dopamine Receptor Agonists as Newer Atypical Antipsychotics:Intrinsic Activity Appropriate for Treatment of Schizophrenic Patients

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 7,Issue: 3
Page: 156-165
Authors: Yuji Odagaki

Dopamine Receptors are Involved in the Control of Opioid Antinociception in Mice

Journal: Letters in Drug Design & Discovery
Volume: 5,Issue: 2
Page: 145-147
Authors: Anna Capasso

Latest Advancements on Serotonin and Dopamine Transporters in Lymphocytes

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 10,Issue: 1
Page: 32-40
Authors: Donatella Marazziti, Giorgio Consoli, Irene Masala, Mario Catena Dell'Osso and Stefano Baroni

Structure-Based Drug Design for Dopamine D3 Receptor

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 15,Issue: 10
Page: 775-791
Authors: Zhiwei Feng, Tingjun Hou and Youyong Li

Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review

Journal: Current Neuropharmacology
Volume: 15,Issue: 1
Page: 174-183
Authors: John Yin, Alasdair M. Barr, Alfredo Ramos-Miguel and Ric M. Procyshyn

Dopamine β-Monooxygenase: Mechanism, Substrates and Inhibitors

Journal: Current Enzyme Inhibition
Volume: 5,Issue: 1
Page: 27-43
Authors: Alexandre Beliaev, Humberto Ferreira, David A. Learmonth and Patricio Soares-da-Silva

D3 Dopamine Receptor and Essential Hypertension

Journal: Current Hypertension Reviews
Volume: 2,Issue: 3
Page: 247-253
Authors: Chunyu Zeng, Gilbert M. Eisner, Robin A. Felder and Pedro A. Jose

D1 and Functionally Selective Dopamine Agonists as Neuroprotective Agents in Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 3
Page: 345-353
Authors: M. M. Lewis, X. Huang, D. E. Nichols and R. B. Mailman

Frontal Lobe Synaptic Plasticity in Development and Disease: Modulation by the Dopamine D1 Receptor

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 32
Page: 5194-5201
Authors: Lynn D. Selemon

Bitropic D3 Dopamine Receptor Selective Compounds s Potential Antipsychotics

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 26
Page: 3700-3724
Authors: Robert R. Luedtke, Claudia Rangel-Barajas, Mahinder Malik, David E. Reichert and R. H. Mach

Agonistic and Antagonistic Bivalent Ligands for Serotonin and Dopamine Receptors Including their Transporters

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 4
Page: 347-353
Authors: Michael Decker and Jochen Lehmann

Is Dopamine Neurotransmission Altered in Prodromal Schizophrenia? A Review of the Evidence

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 12
Page: 1568-1579
Authors: Martin Bauer, Nicole Praschak-Rieder, Siegfried Kasper and Matthaus Willeit

Significant Changes in D2-like Dopamine Gene Receptors Expression Associated with Non- Small -Cell Lung Cancer: Could it be of Potential Use in the Design of Future Therapeutic Strategies?

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 4
Page: 304-310
Authors: Mojhgan Shaikhpoor, Ghasem Ahangari, Majid Sadeghizadeh, Adnan Khosravi and Gholamreza Derakhshani Deilami

4D-QSAR Model for Compounds with Binding Affinity Towards Dopamine D2 Receptors

Journal: Letters in Drug Design & Discovery
Volume: 11,Issue: 5
Page: 649-664
Authors: Daniela Rodrigues Silva, Teodorico C. Ramalho and Elaine F. F. da Cunha

Role of Dimerization in Dopamine D4 Receptor Biogenesis

Journal: Current Protein & Peptide Science
Volume: 15,Issue: 7
Page: 659-665
Authors: Kathleen Van Craenenbroeck, Dasiel O. Borroto-Escuela, Kamila Skieterska, Jolien Duchou, Wilber Romero-Fernandez and Kjell Fuxe

Regulation of Dopamine Signaling in the Striatum by Phosphodiesterase Inhibitors: Novel Therapeutics to Treat Neurological and Psychiatric Disorders

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 72-82
Authors: Andres D. Ramirez and Sean M. Smith

Optimizing Contrast Effect in T1-Weighted Magnetic Resonance Imaging of Gd2O3-Based Nano-Agent via Dopamine Chelation

Journal: Neuroscience and Biomedical Engineering
Volume: 4,Issue: 4
Page: 249-254
Authors: Haitao Huang, Lihui Weng and Jafar Golzarian

Artificial Neural Network (ANN) Based Modelling for D1 Like and D2 Like Dopamine Receptor Affinity and Selectivity

Journal: Medicinal Chemistry
Volume: 6,Issue: 5
Page: 259-270
Authors: Dana A. Karolidis, Snezana Agatonovic-Kustrin and David W. Morton

Unraveling the Dopamine Receptor Signalplex by DRIPs and DRAPs

Journal: Current Proteomics
Volume: 2,Issue: 3
Page: 209-223
Authors: N. Kabbani, M. A. Hannan and R. Levenson

Impulsive and Compulsive Behaviors During Dopamine Replacement Treatment in Parkinson’s Disease and Other Disorders

Journal: Current Drug Safety
Volume: 7,Issue: 1
Page: 63-75
Authors: Michele Raja and Anna Rita Bentivoglio

Postnatal Neurogenesis and Dopamine Alterations in Early Psychosis

Journal: Recent Patents on CNS Drug Discovery
Volume: 7,Issue: 3
Page: 236-242
Authors: Dragos Inta, Juan M. Lima-Ojeda, Peter Gass and Paolo Fusar-Poli

Modulation of Dopamine Transmission by 5HT2C and 5HT3 Receptors: A Role in the Antidepressant Response

Journal: Current Drug Targets
Volume: 7,Issue: 2
Page: 165-175
Authors: Eliyahu Dremencov, Yifat Weizmann, Noa Kinor, Iris Gispan-Herman and Gal Yadid

Evaluation of 2,3,4,8,13a Hexahydro-1H-Benzo[5,6]Cyclohepta-6,7- Dihydroxy[1,2,3-ef][3]Benzazepine Derivatives as Dopamine Receptor Ligands

Journal: Letters in Drug Design & Discovery
Volume: 3,Issue: 1
Page: 55-60
Authors: P. Sozio, F. Pinnen, A. Cocco, I. Cacciatore, G. Giorgioni, B. Costa, M. Montali, G. Spoto, F. Santoleri and Antonio Di Stefano

Molecular Biology, Pharmacology and Functional Role of the Plasma Membrane Dopamine Transporter

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 45-56
Authors: Raul R. Gainetdinov, Marc G. Caron, Jean-Martin Beaulieu and Tatyana D. Sotnikova

Development of Polyfluorophenyltropanes: Potential Probes for 19F Magnetic Resonance Imaging (MRI) and Spectroscopy (MRS) Assessments of the Dopamine Transporter

Journal: Letters in Drug Design & Discovery
Volume: 2,Issue: 4
Page: 302-306
Authors: Ao Zhang, Nora S. Kula, Kehong Zhang, Ross J. Baldessarini, Marc J. Kaufman, Perry F. Renshaw and John L. Neumeyer

Dopamine Neurotransmission and Atypical Antipsychotics in Prefrontal Cortex: A Critical Review

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 21
Page: 2357-2374
Authors: Mercè Masana, Noemí Santana, Francesc Artigas and Analía Bortolozzi

A Computational Perspective on Drug Discovery and Signal Transduction Mechanism of Dopamine and Serotonin Receptors in the Treatment of Schizophrenia

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 10
Page: 916-926
Authors: Peng Lian, Lili Xu, Chuanrong Geng, Yuanyuan Qian, Wei Li, Xuechu Zhen and Wei Fu

Changes in Rat 50-kHz Ultrasonic Vocalizations During Dopamine Denervation and Aging: Relevance to Neurodegeneration

Journal: Current Neuropharmacology
Volume: 13,Issue: 2
Page: 211-219
Authors: Aaron M. Johnson, Laura M. Grant, Timothy Schallert and Michelle R. Ciucci

Controversies of Dopamine Agonists: Somnolence, Cardiac Valvulopathy and Repetitive Behaviors

Journal: Current Drug Therapy
Volume: 2,Issue: 1
Page: 17-20
Authors: Samay Jain and Cheryl H. Waters

A Solution-Phase Combinatorial Synthesis of Selective Dopamine D4 Ligands

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 3,Issue: 1
Page: 43-50
Authors: John P. Williams and Karine Lavrador

The Contribution of Dopamine to the Implementation of Reward Value During the Control of Action

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 8,Issue: 2
Page: 72-84
Authors: Johan Lauwereyns

Dopamine D5 Receptors: A Challenge to Medicinal Chemists

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8,Issue: 10
Page: 976-995
Authors: G. Giorgioni, A. Piergentili, S. Ruggieri and W. Quaglia

Dopamine: The Forgotten Felon in Type 2 Diabetes

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 5,Issue: 1
Page: 61-65
Authors: Sanjay Kalra, Bharti Kalra, Navneet Agrawal and Satish Kumar

Physiological Role of Peroxisome Proliferator-Activated Receptors Type Alpha on Dopamine Systems

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 1
Page: 70-77
Authors: Miriam Melis, Gianfranca Carta, Marco Pistis and Sebastiano Banni

Assessment of a Synthetic Steroid and Flutamide on Dopamine, GSH and H2O2 Levels in Rat Brain in Presence of Fructose

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 14,Issue: 2
Page: 126-133
Authors: David C. Guzman, Eugene Bratoeff, Aylin S. Ortiz, Ernestina H. Garcia, Norma O. Brizuela, Gerardo B. Mejia, Hugo J. Olguin, Daniel S. del Angel and Israel M. Cruz

New Perspective Therapy of Breast Cancer Based on Selective Dopamine Receptor D2 Agonist and Antagonist Effects on MCF-7 Cell Line

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 10,Issue: 2
Page: 214-223
Authors: Majid Pornour, Ghasem Ahangari, Seyed H. Hejazi and Abdolkhalegh Deezagi

The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 25-43
Authors: L. Leriche, E. Bezard, C. Gross, O. Guillin, B. L. Foll, J. Diaz and P. Sokoloff

Dopamine Thioethers in Neurodegeneration

Journal: Current Topics in Medicinal Chemistry
Volume: 1,Issue: 6
Page: 519-527
Authors: Kathrin R. Sidell, Ventkataraman Amarnath and Thomas J. Montine

Neurotensin NTS1-Dopamine D2 Receptor-Receptor Interactions in Putative Receptor Heteromers: Relevance for Parkinson`s Disease and Schizophrenia

Journal: Current Protein & Peptide Science
Volume: 15,Issue: 7
Page: 681-690
Authors: Luca Ferraro, Sarah Beggiato, Dasiel O. Borroto-Escuela, Laura Ravani, William T. O';Connor, Maria C. Tomasini, Andrea C. Borelli, Luigi F. Agnati, Tiziana Antonelli, Sergio Tanganelli and Kjell Fuxe

Genetic Influences in Cannabis Use Disorder and Psychosis: Dopamine and Beyond

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 42
Page: 6392-6396
Authors: Amine Benyamina, Laurent Karila, Geneviève Lafaye and Lisa Blecha

The Role of Transcription Factor Pitx3 in Dopamine Neuron Development and Parkinsons Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 855-859
Authors: Jia Li, John A. Dani and Weidong Le

Synthesis of Novel 4-Aryl-1,2,3,4-tetrahydroisoquinolines as Probes for Dopamine Receptor Ligands

Journal: Medicinal Chemistry
Volume: 8,Issue: 4
Page: 699-704
Authors: Gianfabio Giorgioni, Dario Ambrosini, Giovanni Filippo Palmieri, Barbara Costa, Antonio Di Stefano and Claudia Martini

From Stem Cells to Dopamine Neurons: Developmental Biology Meets Neurodegeneration

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 7
Page: 893-896
Authors: Jignesh Tailor, Thomas Andreska and Raja Kittappa

Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?

Journal: Current Neuropharmacology
Volume: 5,Issue: 4
Page: 268-277
Authors: M. Melis and M. Pistis

Nitric Oxide and Dopamine Neurons. Implications for Parkinsons Disease

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 5,Issue: 3
Page: 193-205
Authors: Maria A. Mena, Maria J. Casarejos and Santiago Canals

Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 8
Page: 643-671
Authors: Robert R. Luedtke and Robert H. Mach

The Discovery of Epidepride and Its Analogs as High-Affinity Radioligands for Imaging Extrastriatal Dopamine D2 Receptors in Human Brain

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 8
Page: 673-696
Authors: Tomas de Paulis

The Control of Dopamine Neuron Development, Function and Survival: Insights From Transgenic Mice and The Relevance to Human Disease

Journal: Current Medicinal Chemistry
Volume: 10,Issue: 10
Page: 857-870
Authors: J. B. Eells

Altered Mesolimbic Dopamine System in THC Dependence

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 200-204
Authors: S. Spiga, A. Lintas and M. Diana

Recent Advances in the Development of Dopamine D3 Receptor Agonists and Antagonists

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 1,Issue: 1
Page: 89-99
Authors: A. Michael Crider and Mark A. Scheideler

Dopamine Neurons in the Ventral Tegmental Area: Drug-induced Synaptic Plasticity and Its Role in Relapse to Drug-seeking Behavior

Journal: Current Drug Abuse Reviews
Volume: 4,Issue: 4
Page: 270-285
Authors: WenLin Sun

Recent Developments in the Discovery of Novel Antipsychotic Agents Modualating Dopamine and Serotonin Receptors

Journal: Current Drug Targets
Volume: 14,Issue: 8
Page: 899-918
Authors: Xin Li and Shutao Ma

Modeling of Dopamine D2 Receptor - Overview of 35-Year Evolution

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 25
Page: 2972-2990
Authors: Vladimir Sukalovic, Vukic Soskic and Sladjana Kostic-Rajacic

Progress in the Search for New Dopamine Transporter Inhibitors

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 28
Page: 3255-3277
Authors: Beata Gryzlo, Paula Zareba, Katarzyna Malawska, Anna Jakubowska and Katarzyna Kulig

Revisiting the Medical Management of Parkinson’s Disease: Levodopa versus Dopamine Agonist

Journal: Current Neuropharmacology
Volume: 14,Issue: 4
Page: 356-363
Authors: Jinglin Zhang and Louis Chew-Seng Tan

Dopamine-Glutamate Interaction and Antipsychotics Mechanism of Action: Implication for New Pharmacological Strategies in Psychosis

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 27
Page: 3561-3594
Authors: A. de Bartolomeis, G. Fiore and F. Iasevoli

Abnormal Striatal Dopamine Transmission in Schizophrenia

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 397-404
Authors: Jerome Brunelin, Shirley Fecteau and Marie-Francoise Suaud-Chagny

Combining Stress and Dopamine Based Models of Addiction: Towards a Psycho-Neuro-Endocrinological Theory of Addiction

Journal: Current Drug Abuse Reviews
Volume: 9,Issue: 1
Page: 61-74
Authors: James H. Johnston, David E.J. Linden and Marianne B.M. van den Bree

Serotonin-Dopamine Interaction as a Focus of Novel Antidepressant Drugs

Journal: Current Drug Targets
Volume: 7,Issue: 2
Page: 177-185
Authors: Ennio Esposito

Capillary Electrophoresis Study on DNA-Protein Complex Formation in the Polymorphic 5 Upstream Region of the Dopamine D4 Receptor (DRD4) Gene

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 8
Page: 1023-1029
Authors: Z. Ronai, A. Guttman, G. Keszler and M. Sasvari-Szekely

Filtering Disturbances in Schizophrenic Patients. Gating of Auditory Evoked Potentials and Prepulse Inhibition of the Acoustic Startle Response Compared. Emphasis on the Role of Dopamine

Journal: Current Neuropharmacology
Volume: 1,Issue: 1
Page: 47-87
Authors: N. M.W.J. de Bruin, E. L.J.M. van Luijtelaar, A. R. Cools and B. A. Ellenbroek

Simultaneous Determination of Dopamine and Uric Acid in the Presence of Ascorbic Acid at the Indole-3-Carboxaldehyde Modified Glassy Carbon Electrode

Journal: Current Analytical Chemistry
Volume: 6,Issue: 3
Page: 203-208
Authors: Didem Deletioglu, Erdogan Hasdemir and Ali O. Solak

Dopamine Transporter Ligands: Recent Developments and Therapeutic Potential

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 17
Page: 1825-1843
Authors: Scott P. Runyon and F. Ivy Carroll

Selective Dopamine D3 Receptor Antagonists: A Review 2001-2005

Journal: Recent Patents on CNS Drug Discovery
Volume: 1,Issue: 3
Page: 271-288
Authors: Fabrizio Micheli and Christian Heidbreder

Structure-Activity Relationships for Serotonin Transporter and Dopamine Receptor Selectivity

Journal: Medicinal Chemistry
Volume: 5,Issue: 3
Page: 271-278
Authors: Snezana Agatonovic-Kustrin, Paul Davies and Joseph V. Turner

Current State of Agonist Radioligands for Imaging of Brain Dopamine D2/D3 Receptors In Vivo with Positron Emission Tomography

Journal: Current Topics in Medicinal Chemistry
Volume: 10,Issue: 15
Page: 1477-1498
Authors: Sjoerd J. Finnema, Benny Bang-Andersen, Hakan V. Wikstrom and Christer Halldin

Predicting Dopamine Receptors Binding Affinity of N-[4-(4-Arylpiperazin- 1-yl) butyl]Aryl Carboxamides: Computational Approach Using Topological Descriptors

Journal: Current Drug Discovery Technologies
Volume: 2,Issue: 2
Page: 115-121
Authors: Viney Lather and A. K. Madan

Selective Dopamine D4 Receptor Antagonists: Review ofStructure-Activity Relationships

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 2,Issue: 4
Page: 259-274
Authors: Kehong Zhang, Ross J. Baldessarini, Frank I. Tarazi and John L. Neumeyer

Role of the Dopamine Transporter in the Action of Psychostimulants, Nicotine, and Other Drugs of Abuse

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 5
Page: 393-409
Authors: J. Zhu and M. E.A. Reith

Selective Antagonism at Dopamine D3 Receptors as a Target for Drug Addiction Pharmacotherapy: A Review of Preclinical Evidence

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 5
Page: 410-421
Authors: Christian Heidbreder

Parallel Roles for Dopamine in Pathological Gambling and Psychostimulant Addiction

Journal: Current Drug Abuse Reviews
Volume: 2,Issue: 1
Page: 11-25
Authors: Martin Zack and Constantine X. Poulos

Dopamine D1 Receptors, Regulation of Gene Expression in the Brain, and Neurodegeneration

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 5
Page: 526-538
Authors: Jean Lud Cadet, Subramaniam Jayanthi, Michael T. McCoy, Genevieve Beauvais and Ning Sheng Cai

Prime Time for G-Protein-Coupled Receptor Heteromers as Therapeutic Targets for CNS disorders: The Dopamine D1-D3 Receptor Heteromer

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 5
Page: 596-600
Authors: Sergi Ferre, Carmen Lluis, Jose Luis Lanciego and Rafael Franco

Targeted D4 Dopamine Receptors: Implications for Drug Discovery and Therapeutic Development

Journal: Current Drug Targets
Volume: 14,Issue: 4
Page: 507-512
Authors: Radek Ptacek, Hana Kuzelova, George B. Stefano, Jiri Raboch and Richard M. Kream

The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico- Subcortical Regions

Journal: Current Molecular Pharmacology
Volume: 6,Issue: 3
Page: 149-155
Authors: Felice Iasevoli, Luigi Aloj, Gianmarco Latte, Livia Avvisati, Federica Marmo, Carmine Tomasetti, Elisabetta F. Buonaguro, Chiara Simeoli, Rosario Pivonello, Annamaria Colao and Andrea de Bartolomeis

Region-Specific Dendritic Spine Loss of Pyramidal Neurons in Dopamine Transporter Knockout Mice

Journal: Current Molecular Medicine
Volume: 15,Issue: 3
Page: 237-244
Authors: Y. Kasahara, Y. Arime, F.S. Hall, G.R. Uhl and I. Sora

Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 29
Page: 3385-3403
Authors: Peng Li, Gretchen L. Snyder and Kimberly E. Vanover

HIV-1 Proteins, Tat and gp120, Target the Developing Dopamine System

Journal: Current HIV Research
Volume: 13,Issue: 1
Page: 21-42
Authors: Sylvia Fitting, Rosemarie M. Booze and Charles F. Mactutus

On the Origin of Cortical Dopamine: Is it a Co-Transmitter in Noradrenergic Neurons?

Journal: Current Neuropharmacology
Volume: 4,Issue: 2
Page: 115-125
Authors: Paola Devoto and Giovanna Flore

mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias

Journal: Current Neuropharmacology
Volume: 14,Issue: 5
Page: 481-493
Authors: Nicolas Morin, Marc Morissette, Laurent Grégoire and Thérèse Di Paolo

Modulation of Midbrain Dopamine Neurotransmission by Serotonin, a Versatile Interaction Between Neurotransmitters and Significance for Antipsychotic Drug Action

Journal: Current Neuropharmacology
Volume: 4,Issue: 1
Page: 59-68
Authors: J. E. Olijslagers, T. R. Werkman, A. C. McCreary, C. G. Kruse and W. J. Wadman

Targeting Exocytosis: Ins and Outs of the Modulation of Quantal Dopamine Release

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 1
Page: 57-77
Authors: Remco H.S. Westerink

Restoration of the Striatal Dopamine Synthesis for Parkinsons Disease:Viral Vector-Mediated Enzyme Replacement Strategy

Journal: Current Gene Therapy
Volume: 7,Issue: 2
Page: 109-120
Authors: Thomas Carlsson, Tomas Bjorklund and Deniz Kirik

An Update on Adenosine A2A-Dopamine D2 Receptor Interactions: Implications for the Function of G Protein-Coupled Receptors

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 15
Page: 1468-1474
Authors: S. Ferre, C. Quiroz, A. S. Woods, R. Cunha, P. Popoli, F. Ciruela, C. Lluis, R. Franco, K. Azdad and S. N. Schiffmann

Prospect of a Dopamine Contribution in the Next Generation of Antidepressant Drugs: The Triple Reuptake Inhibitors

Journal: Current Drug Targets
Volume: 10,Issue: 11
Page: 1069-1084
Authors: Bruno P. Guiard, Mostafa El Mansari and Pierre Blier

The Importance of the Adenosine A2A Receptor-Dopamine D2 Receptor Interaction in Drug Addiction

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 3
Page: 317-355
Authors: M. Filip, M. Zaniewska, M. Frankowska, K. Wydra and K. Fuxe

D2 Receptor Partial Agonists: Treatment of CNS Disorders of Dopamine Function

Journal: Current Topics in Medicinal Chemistry
Volume: 8,Issue: 12
Page: 1068-1088
Authors: John H. Kehne, Terrance H. Andree and Julia N. Heinrich

The Role of Autophagy on the Survival of Dopamine Neurons

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 869-879
Authors: Ciro Isidoro, Francesca Biagioni, Filippo Sean Giorgi, Federica Fulceri, Antonio Paparelli and Francesco Fornai

Behavioural Sensitisation During Dopamine Replacement Therapy in Parkinsons Disease is Reminiscent of the Addicted Brain

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 894-902
Authors: F. Biagioni, A. Pellegrini, S. Ruggieri, L. Murri, A. Paparelli and F. Fornai1

Glutamate mGlu5-Adenosine A2A-Dopamine D2 Receptor Interactions in the Striatum. Implications for Drug Therapy in Neuro-psychiatric Disorders and Drug Abuse

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 3,Issue: 1
Page: 1-26
Authors: Sergi Ferre, Francisco Ciruela, Amina S. Woods, Meritxell Canals, Javier Burgueno, Daniel Marcellino, Marzena Karcz-Kubicha, Bruce T. Hope, Marisela Morales, Patrizia Popoli, Steven R. Goldberg, Kjell Fuxe, Carme Lluis, Rafael Franco and Luigi Agnati

α-Synuclein- and MPTP-Generated Rodent Models of Parkinsons Disease and the Study of Extracellular Striatal Dopamine Dynamics: A Microdialysis Approach

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 4
Page: 482-490
Authors: Gianfranco Bazzu, Giammario Calia, Giulia Puggioni, Ylenia Spissu, Gaia Rocchitta, Patrizia Debetto, Jessica Grigoletto, Morena Zusso, Rossana Migheli, Pier Andrea Serra, Maria Speranza Desole and Egidio Miele

Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 9,Issue: 2
Page: 94-101
Authors: Michel C.F. Shamy, Clement Zai, Vincenzo S. Basile, James L. Kennedy, Daniel J. Muller and Mario Masellis

Frequency of Pituitary Tumor Apoplexy During Treatment of Prolactinomas with Dopamine Agonists: A Systematic Review

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 8
Page: 1012-1014
Authors: Robert Carija and Diana Vucina

Poly (Rhodamine B) and MWCNTs Composite Film for the Separation and Simultaneous Voltammetric Quantification of Tryptophan, Paracetamol, Uric Acid, Dopamine and Ascorbic Acid

Journal: Current Analytical Chemistry
Volume: 11,Issue: 2
Page: 87-95
Authors: Hayati Filik, Asiye Aslıhan Avan, Sevda Aydar and Re sat Apak

Increased Mitochondrial DNA Deletions in Substantia Nigra Dopamine Neurons of the Aged Rat

Journal: Current Aging Science
Volume: 7,Issue: 3
Page: 155-160
Authors: Gemma M. Parkinson, Christopher V. Dayas and Doug W. Smith

Dopamine D3 Agonists in the Treatment of Parkinson's Disease

Journal: Current Topics in Medicinal Chemistry
Volume: 15,Issue: 10
Page: 908-926
Authors: Banibrata Das, Gyan Modi and Aloke Dutta

The Piccolo Intronic Single Nucleotide Polymorphism rs13438494 Regulates Dopamine and Serotonin Uptake and Shows Associations with Dependence-Like Behavior in Genomic Association Study

Journal: Current Molecular Medicine
Volume: 15,Issue: 3
Page: 265-274
Authors: K. Uno, D. Nishizawa, S. Seo, K. Takayama, S. Matsumura, N. Sakai, K. Ohi, T. Nabeshima, R. Hashimoto, N. Ozaki, J. Hasegawa, N. Sato, F. Tanioka, H. Sugimura, K.-I.- Fukuda, S. Higuchi, H. Ujike, T. Inada, N. Iwata, I. Sora, M. Iyo, N. Kondo, M.-J. Won, N. Naruse, K. Uehara-Aoyama, M. Itokawa, M. Yamada, K. Ikeda, Y. Miyamoto and A. Nitta

Dopamine D4 Receptor Antagonists for the Treatment of Cocaine Use Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 6
Page: 707-715
Authors: Jack Bergman and Curtis G. Rheingold

Antidepressant-induced Dopamine Receptor Dysregulation: A Valid Animal Model of Manic-Depressive Illness

Journal: Current Neuropharmacology
Volume: 15,Issue: 3
Page: 417-423
Authors: Francesca Demontis, Francesca Serra and Gino Serra

Dual Ligands Targeting Dopamine D2 and Serotonin 5-HT1A Receptors as New Antipsychotical or Anti-Parkinsonian Agents

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 4
Page: 437-457
Authors: Na Ye, Zilan Song and Ao Zhang

Nucleus Accumbens Dopamine and the Forebrain Circuitry Involved in Behavioral Activation and Effort-Related Decision Making: Implications for Understanding Anergia and Psychomotor Slowing in Depression

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 2
Page: 267-280
Authors: John D. Salamone, Merce Correa, Susana M. Mingote, Suzanne M. Weber and Andrew M. Farrar

Noninvasive Genotyping of Dopamine Receptor D4 (DRD4) UsingNanograms of DNA From Substance-Dependent Patients

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 8
Page: 793-797
Authors: K. Boor, Z. Ronai, Z. Nemoda, P. Gaszner, M. Sasvari-Szekely, A. Guttman and H. Kalasz

Dopamine Pharmacological Agents in Resistant-OCD

Journal: Current Psychopharmacology
Volume: 1,Issue: 1
Page: 44-46
Authors: Stefano Pallanti, Giacomo Grassi and Iuliia Burian


Sex Hormones and Brain Dopamine Functions

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 62-71
Authors: Ramon Sotomayor-Zarate, Gonzalo Cruz, Georgina M. Renard, Pedro Espinosa and Victor D. Ramirez

Commentary-2: Repairing the Dopamine System in the Brain with Adult Neurogenesis

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 10
Page: 1635-1636
Authors: Ti-Fei Yuan and Oscar Arias-Carrion

Editorial (Thematic Issue: Dopamine in the Brain)

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 61-61
Authors: Victor D. Ramirez

Editorial (Thematic Issue: Current Approaches for Antipsychotics in Drug Discovery: Hope Beyond the Dopamine D2 Receptor?)

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 26
Page: 3698-3699
Authors: Ronan Depoortère


Medications Acting on the Dopaminergic System in the Treatment of Alcoholic Patients

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 19
Page: 2136-2140
Authors: Robert Swift

Neuropharmacological Mechanisms Underlying the Neuroprotective Effects of Methylphenidate

Journal: Current Neuropharmacology
Volume: 6,Issue: 4
Page: 379-385
Authors: T. J. Volz

Assessing Dopaminergic Neurotransmission with PET: Basic Theory and Applications in Alcohol Research

Journal: Current Medical Imaging Reviews
Volume: 7,Issue: 2
Page: 118-124
Authors: Karmen K. Yoder, David A. Kareken and Evan D. Morris

Roles of a Novel Molecule ‘Shati’ in the Development of Methamphetamine-Induced Dependence

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 104-108
Authors: Minae Niwa and Toshitaka Nabeshima

Regulation of Corticostriatal Synaptic Plasticity by G Protein-Coupled Receptors

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 5
Page: 601-615
Authors: Rakel Lopez de Maturana and Rosario Sanchez-Pernaute

Individual Differences and Vulnerability to Drug Addiction: A Focus on the Endocannabinoid System

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 4
Page: 502-517
Authors: Claudia Sagheddu and Miriam Melis

Genetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 12
Page: 1580-1592
Authors: Thomas L. Schwartz, Shilpa Sachdeva and Stephen M. Stahl

Neuroleptics and Migraine

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 63-70
Authors: Petcharat Dusitanond and William B. Young

Reactive Astrocytes as Potential Manipulation Targets in Novel Cell Replacement Therapy of Parkinsons Disease

Journal: Current Drug Targets
Volume: 6,Issue: 7
Page: 821-833
Authors: L- W. Chen, K- L. Yung and Y- S. Chan

Functional Neurochemistry of Alzheimers Disease

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 3
Page: 265-293
Authors: Wieland Gsell, Gerd Jungkunz and Peter Riederer

Current Strategies for the Development of Novel Antipsychotic Drugs

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 3,Issue: 3
Page: 239-251
Authors: Jordi Bolos

Muscarinic Receptors as a Target for Drugs Treating Schizophrenia

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 1,Issue: 2
Page: 163-181
Authors: Frank P. Bymaster, Christian Felder, Saeed Ahmed and David McKinzie

Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 38
Page: 5837-5854
Authors: Kenneth Blum, Marcelo Febo, Rajendra D. Badgaiyan, Eric R. Braverman, Kristina Dushaj, Mona Li and Zsolt Demetrovics

The NMDA/D1 Receptor Complex as a New Target in Drug Development

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 8
Page: 801-808
Authors: Cristina Missale, Chiara Fiorentini, Chiara Busi, Ginetta Collo and P. F. Spano

Noradrenaline in Parkinsons Disease: From Disease Progression to Current Therapeutics

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 22
Page: 2330-2334
Authors: Francesco Fornai, Adolfo Bandettini di Poggio, Antonio Pellegrini, Stefano Ruggieri and Antonio Paparelli

Anti-Inflammatory Agents in Parkinsons Disease

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 8,Issue: 1
Page: 72-84
Authors: Carla Iarlori

Dopaminergic Modulation of Cognitive Control: Distinct Roles for the Prefrontal Cortex and the Basal Ganglia

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 18
Page: 2026-2032
Authors: Martine van Schouwenburg, Esther Aarts and Roshan Cools

From the Prodrome to Chronic Schizophrenia: The Neurobiology Underlying Psychotic Symptoms and Cognitive Impairments

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 4
Page: 459-465
Authors: O. D. Howes, P. Fusar-Poli, M. Bloomfield, S. Selvaraj and P. McGuire

Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA Treatment

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 251-263
Authors: Stefano Espinoza, Francesca Manago, Damiana Leo, Tatyana D. Sotnikova and Raul R. Gainetdinov

The Function of Tyrosine Hydroxylase in the Normal and Parkinsonian Brain

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 381-386
Authors: Christopher Tolleson and Daniel Claassen

PET Tracers for Imaging of the Dopaminergic System

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 18
Page: 2139-2153
Authors: Kentaro Hatano, Kiichi Ishiwata and Philip H. Elsinga

Novel Therapeutic Effects of the Anti-Convulsant, Zonisamide, on Parkinsons Disease

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 6
Page: 687-693
Authors: M. Murata

Catecholaminergic Strategies for the Treatment of Major Depression

Journal: Current Drug Targets
Volume: 7,Issue: 2
Page: 149-158
Authors: Philippe Tremblay and Pierre Blier

Liquiritigenin Decreases Selective Molecular and Behavioral Effects of Cocaine in Rodents

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 30-34
Authors: E. Y. Jang, M. Hwang, S. S. Yoon, J. R. Lee, K. J. Kim, H.-C. Kim and C. H. Yang

Personality and Genetics

Journal: Current Psychiatry Reviews
Volume: 3,Issue: 2
Page: 147-159
Authors: Alessandro Serretti, Raffaella Calati, Barbara Ferrari and Diana De Ronchi

Synthesis and Pharmacological Evaluation of 4-Phenoxy-1,2,3,4- Tetrahydroisoquinolines and 4,5,6,6a-Tetrahydrochromeno [2,3,4-de]isoquinolines

Journal: Medicinal Chemistry
Volume: 4,Issue: 1
Page: 1-10
Authors: G. Giorgioni, S. Ruggieri, F. Claudi, A. Di Stefano, E. Ljung and T. Carlsson

Endocannabinoids and Drug Dependence

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 4,Issue: 6
Page: 643-655
Authors: Daniela Parolaro, Daniela Vigano and Tiziana Rubino

Novel Approaches in the Treatment of Antipsychotic-Induced Hyperprolactinemia:The Role of Partial Agonists of D2 Dopaminergic Receptors

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 4,Issue: 3
Page: 230-240
Authors: Domenico De Berardis, Tiziano Acciavatti, Daniela Campanella, Nicola Serroni, Luigi Olivieri, Carla Ranalli, Viviana Marasco, Alessandro Carano, Marilde Cavuto, Giuseppe Di Iorio, Monica Piersanti, Francesco S. Moschetta and Massimo Di Giannantonio

Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease

Journal: Current Neuropharmacology
Volume: 5,Issue: 1
Page: 35-46
Authors: Randy L. Hunter and Guoying Bing

Functional Imaging of Neurotransmission

Journal: Current Medical Imaging Reviews
Volume: 3,Issue: 4
Page: 220-224
Authors: Alan J. Fischman and Rajendra D. Badgaiyan

Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate

Journal: Current Neuropharmacology
Volume: 6,Issue: 4
Page: 322-328
Authors: Veronika Engert and Jens C. Pruessner

Effects of Behavioral and Neurochemical Changes on Adult Excitotoxic Lesion of the Ventral Hippocampus

Journal: Medicinal Chemistry
Volume: 3,Issue: 3
Page: 255-260
Authors: Yi Ru Fang, Tomohiro Abekawa, Koki Ito, Xiao Bai Li and Tsukasa Koyama

GDNF Family Ligands: A Potential Future for Parkinson's Disease Therapy

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 6
Page: 703-711
Authors: Amanda L. Mickiewicz and Jeffrey H. Kordower

The Role of Catechol-O-Methyltransferase in Reward Processing and Addiction

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 306-323
Authors: E. M. Tunbridge, A. Huber, S. M. Farrell, K. Stumpenhorst, P. J. Harrison and M. E. Walton

Exploration of N-arylpiperazine Binding Sites of D2 Dopaminergic Receptor

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 15,Issue: 12
Page: 988-1001
Authors: Vukic Soskic, Vladimir Sukalovic and Sladjana Kostic-Rajacic

Approaches to Enantiomerically Pure 3,4-Dihydro-2H-1-Benzopyran-3-Amines

Journal: Current Organic Chemistry
Volume: 14,Issue: 6
Page: 581-600
Authors: A. Beliaev, B. Broadbelt and D. A. Learmonth

Carbohydrate Reward and Psychosis: An Explanation For Neuroleptic Induced Weight Gain and Path to Improved Mental Health?

Journal: Current Neuropharmacology
Volume: 9,Issue: 2
Page: 370-375
Authors: Simon Thornley, Bruce Russell and Rob Kydd

Pharmacological Therapy of Parkinsons Disease: Current Options and New Avenues

Journal: Recent Patents on CNS Drug Discovery
Volume: 5,Issue: 3
Page: 221-238
Authors: Nicola Simola, Annalisa Pinna and Sandro Fenu

Piribedil: Antiparkinsonian Properties and Potential Clinical Utility in Dopaminergic Disorders

Journal: Current Drug Therapy
Volume: 6,Issue: 1
Page: 17-34
Authors: Aravind Mittur

Potential Application of Induced Pluripotent Stem Cells in Cell Replacement Therapy for Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 4
Page: 449-458
Authors: L. W. Chen, F. Kuang, L. C. Wei, Y. X. Ding, K. K.L. Yung and Y. S. Chan

A Candidate Pathway Strategy for Integration of Pharmacogenomic Components of Variability in Antipsychotic Treatment Outcomes: A Focus on Aripiprazole

Journal: Current Pharmacogenomics
Volume: 3,Issue: 4
Page: 305-317
Authors: Christopher Reist, Lawrence J. Albers, Stephen R. Marder, Bryn Williams-Jones, Joseph C. Wu, Steven Mee, Kazutaka Shimoda, Toshiyuki Someya and Vural Ozdemir

The “Parkinsonian Heart”: From Novel Vistas to Advanced Therapeutic Approaches in Parkinsons Disease

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 23
Page: 2421-2428
Authors: Francesco Fornai, Riccardo Ruffoli, Paola Soldani, Stefano Ruggieri and Antonio Paparelli

A Review of Current Drug Targets and Pharmacology of Antipsychotic Treatment

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 2,Issue: 3
Page: 177-182
Authors: Robert R. Conley and Deanna L. Kelly

Current Status of Antipsychotic Treatment

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 1,Issue: 2
Page: 123-128
Authors: Robert R. Conley and Deanna L. Kelly

Caffeine as a Lead Compound for the Design of Therapeutic Agents for the Treatment of Parkinson’s Disease

Journal: Current Medicinal Chemistry
Volume: 22,Issue: 8
Page: 975-988
Authors: Jacobus P. Petzer and Anel Petzer

Evolution of Antipsychotic Intervention in the Schizophrenic Psychosis

Journal: Current Drug Targets
Volume: 7,Issue: 9
Page: 1205-1215
Authors: David L. Garver

Schizophrenia and Bipolar Affective Disorder: Perspectives for the Development of Therapeutics

Journal: Current Molecular Medicine
Volume: 3,Issue: 5
Page: 393-407
Authors: S. Sundram, P. R. Joyce and M. A. Kennedy

Working Memory in ADHD: Prefrontal/Parietal Connections

Journal: Current Drug Targets
Volume: 2,Issue: 4
Page: 347-352
Authors: F Levy and M Farrow

PET Imaging in Parkinsons Disease

Journal: Current Medical Imaging Reviews
Volume: 3,Issue: 4
Page: 233-241
Authors: Vijay Dhawan and David Eidelberg

The Neuropharmacology of Implicit Learning

Journal: Current Neuropharmacology
Volume: 8,Issue: 4
Page: 367-381
Authors: Julia Udden, Vasiliki Folia and Karl Magnus Petersson

Alpha7 Neuronal Nicotinic Receptors as Targets for Novel Therapies to Treat Multiple Domains of Schizophrenia

Journal: Current Pharmaceutical Biotechnology
Volume: 12,Issue: 3
Page: 437-448
Authors: Aaron J. Kucinski, Michal K. Stachowiak, Scott R. Wersinger, Patrick M. Lippiello and Merouane Bencherif

Neurotransmitter Imaging: Basic Concepts and Future Perspectives

Journal: Current Medical Imaging Reviews
Volume: 7,Issue: 2
Page: 98-103
Authors: Rajendra D. Badgaiyan

Schizophrenia: Redox Regulation and Volume Neurotransmission

Journal: Current Neuropharmacology
Volume: 9,Issue: 2
Page: 289-300
Authors: I. Bokkon and I. Antal

The Sensation Seeking Trait and Substance Use: Research Findings and Clinical Implications

Journal: Current Psychiatry Reviews
Volume: 3,Issue: 1
Page: 3-13
Authors: Michael T. Bardo, Yolanda Williams, Linda P. Dwoskin, S. E. Moynahan, I. B. Perry and Catherine A. Martin

Endogenous Opioids and Addiction to Alcohol and other Drugs of Abuse

Journal: Current Topics in Medicinal Chemistry
Volume: 4,Issue: 1
Page: 39-50
Authors: Christina Gianoulakis

Endogenous Opioids and Addiction to Alcohol and other Drugs of Abuse

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 11
Page: 999-1015
Authors: Christina Gianoulakis

Therapeutic Implications of Immune-endocrine Interactions in the Critically Ill Patients

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 4,Issue: 2
Page: 129-139
Authors: Reiner Oberbeck

Anti-Parkinsonian Effects of Nurr1 Activator in Ubiquitin-Proteasome System Impairment Induced Animal Model of Parkinson’s Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 6
Page: 768-773
Authors: Zhen Zhang, Xuping Li, Wen-jie Xie, Houzhen Tuo, Samuel Hintermann, Joseph Jankovic and Weidong Le

The Role of α5 GABAAReceptor Agonists in the Treatment of Cognitive Deficits in Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 31
Page: 5069-5076
Authors: Kathryn M. Gill and Anthony A. Grace

An Overview on Benzylisoquinoline Derivatives with Dopaminergic and Serotonergic Activities

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 19
Page: 2441-2467
Authors: N. Cabedo, I. Berenguer, B. Figadere and D. Cortes

PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 2
Page: 137-150
Authors: Jan Kehler and Jacob Nielsen

Commentary

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 192-192
Authors: Stephen D. Skaper

Catechol-O-Methyl Transferase Modulates Cognition in Late Life: Evidence and Implications for Cognitive Enhancement

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 195-208
Authors: Fabio Sambataro, Maria Pennuto and Robert Christian Wolf

Current Status of Tyrosine Hydroxylase in Management of Parkinson’s Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 450-455
Authors: Annaik Petithomme Feve

Therapeutic Potential of Natural Products in Parkinson’s Disease

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 6,Issue: 3
Page: 181-200
Authors: Rajeswara B. Mythri, Gangadharappa Harish and M. M. Bharath

Pathological Gambling in Parkinson’s Disease: An Update on Medical Management

Journal: Current Psychopharmacology
Volume: 1,Issue: 4
Page: 365-374
Authors: Domenico Pirritano, Massimiliano Plastino, Antonietta Fava, Dario Cristiano, Luca Gallelli, Carmela Colica and Domenico Bosco

Agonist Replacement for Stimulant Dependence: A Review of Clinical Research

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 40
Page: 7026-7035
Authors: William W. Stoops and Craig R. Rush

Dopaminergic Enhancement of Cognitive Function

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 20
Page: 2487-2500
Authors: Mitul A. Mehta and Wim J. Riedel

Recent Progress in Medicinal Chemistry of D4 Agonists

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 25
Page: 2981-2993
Authors:

Progress in the Preparation and Testing of Glycine Transporter Type-1 (GlyT1) Inhibitors

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 17
Page: 1883-1896
Authors: Craig W. Lindsley, Scott E. Wolkenberg and Gene G. Kinney

Metamphetamine Psychosis: How is it Related to Schizophrenia? A Review of the Literature

Journal: Current Psychiatry Reviews
Volume: 1,Issue: 2
Page: 115-122
Authors: Melinda Sweeting and Michael Farrell

The Role of Cytokine Network in the Pathophysiology of Schizophrenia

Journal: Current Psychiatry Reviews
Volume: 1,Issue: 2
Page: 123-131
Authors: Yong-Ku Kim

Clinical Pharmacology of Paliperidone Palmitate A Parenteral Long-Acting Formulation for the Treatment of Schizophrenia

Journal: Reviews on Recent Clinical Trials
Volume: 7,Issue: 1
Page: 2-9
Authors: Elizabeth Gilday and Henry A. Nasrallah

Triple Reuptake Inhibitors (“Broad Spectrum” Antidepressants)

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6,Issue: 2
Page: 141-149
Authors: Phil Skolnick and Anthony S. Basile

Chinese Herbs and Herbal Extracts for Neuroprotection of Dopaminergic Neurons and Potential Therapeutic Treatment of Parkinson’s Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6,Issue: 4
Page: 273-281
Authors: Liang-Wei Chen, Yan-Qin Wang, Li-Chun Wei, Mei Shi and Ying-Shing Chan

An Update on Adenosine A2A Receptors as Drug Target in Parkinson's Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 6
Page: 659-669
Authors: Antoni Vallano, Víctor Fernandez-Duenas, Consuelo Pedros, Josep Maria Arnau and Francisco Ciruela

Recent Advances in Targeting the Ionotropic Glutamate Receptors in Treating Schizophrenia

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 8
Page: 1535-1542
Authors: Robert E. McCullumsmith, John Hammond, Adam Funk and James H. Meador-Woodruff

Electrochemical Pretreatment of Carbon Fiber Microelectrodes Based on Sinusoidal-wave Potential Cycling and its Application to Amperometric Sensing of Bioactive Compounds

Journal: Current Analytical Chemistry
Volume: 9,Issue: 2
Page: 305-311
Authors: Vladimir Halouzka, Jan Hrbac, David Jirovsky, Daniel Riman, Petr Jakubec, Zdenka Bartosova, Vlastimil Masek, Peter Mojzes and Jan Vacek

Fluorinated Tropanes

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 8
Page: 920-935
Authors: Jeffrey S. Stehouwer

Pharmacogenetics of Parkinson’s Disease – Through Mechanisms of Drug Actions

Journal: Current Genomics
Volume: 14,Issue: 8
Page: 568-577
Authors: Marek Drozdzik, Monika Bialecka and Mateusz Kurzawski

Intracellular Signaling and Approaches to the Treatment of Schizophrenia and Associated Cognitive Impairment

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 31
Page: 5093-5103
Authors: Gretchen L. Snyder and Kimberly E. Vanover

Role of Ghrelin in Drug Abuse and Reward-Relevant Behaviors: A Burgeoning Field and Gaps in the Literature

Journal: Current Drug Abuse Reviews
Volume: 6,Issue: 3
Page: 231-244
Authors: A.R. Revitsky and L.C. Klein

Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 3
Page: 313-324
Authors: Beatrice Macchi, Rosanna Di Paola, Francesca Marino-Merlo, Maria Rosa Felice, Salvatore Cuzzocrea and Antonio Mastino

Effect of two Antiandrogens as Protectors of Prostate and Brain in a Huntington`s Animal Model

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 9
Page: 1293-1301
Authors: David Calderon Guzman, Eugene Bratoeff, Alejandra Chavez Riveros, Norma Osnaya Brizuela, Gerardo Barragan Mejia, Ernestina Hernandez Garcia, Hugo Juarez Olguin and Edna Garcia Cruz

Pharmacological Profile of Antipsychotics at Monoamine Receptors: Atypicality Beyond 5-HT2A Receptor Blockade

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 4
Page: 445-452
Authors: Martyn D. Wood, Claire Scott, Kirsten Clarke, Katherine J. Cato, Nisha Patel, Jennie Heath, Angela Worby, Laurie Gordon, Lorraine Campbell, Graham Riley, Ceri H. Davies, Andrew Gribble and Declan N.C. Jones

Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases

Journal: Current Drug Targets
Volume: 7,Issue: 11
Page: 1513-1529
Authors: Manuchair Ebadi, Holly Brown-Borg, Jun Ren, Sushil Sharma, Shaik Shavali, Hesham El ReFaey and Edward C. Carlson

An Overview of Parkinsons Disease and the Cannabinoid System and Possible Benefits of Cannabinoid-Based Treatments

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 30
Page: 3705-3718
Authors: Isabel Lastres-Becker and Javier Fernandez-Ruiz

Glutamate and Schizophrenia

Journal: Current Neuropharmacology
Volume: 1,Issue: 4
Page: 351-370
Authors: B. N.M. van Berckel

Positron Emission Tomography and Brain Monoamine Neurotransmission - Entries for Study of Drug Interactions

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 16
Page: 1417-1434
Authors: P. Hartvig, M. Bergstrom, G. Antoni and B. Langstrom

Parkinsons Disease - Redox Mechanisms

Journal: Current Medicinal Chemistry
Volume: 8,Issue: 7
Page: 809-814
Authors: James David Adams Jr., Mei-Ling Chang and Lori Klaidman

Recent Developments in Studies of l-Stepholidine and its Analogs: Chemistry, Pharmacology and Clinical Implications

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 28
Page: 2996-3002
Authors: Jiao Mo, Yang Guo, Yu-She Yang, Jing-Shan Shen, Guo-Zhang Jin and Xuechu Zhen

Adenosine A2A Receptor Antagonists and Parkinsons Disease: State of the Art and Future Directions

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 15
Page: 1475-1489
Authors: N. Simola, M. Morelli and A. Pinna


Pharmacogenetic Approach for a Better Drug Treatment in Children

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 22
Page: 2462-2473
Authors: Guilherme Polanczyk, Marcelo P. Bigarella, Mara H. Hutz and Luis Augusto Rohde

Exploring Mechanisms Underlying Extinction of Cue-Elicited Cocaine Seeking

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 8-11
Authors: Han Kong and Ming Xu

Role of Nitric Oxide in Motor Control: Implications for Parkinsons Disease Pathophysiology and Treatment

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 5
Page: 471-488
Authors: Elaine Del-Bel, Fernando Eduardo Padovan-Neto, Rita Raisman-Vozari and Marcio Lazzarini

Oxidation Chemistry of Catecholamines and Neuronal Degeneration: An Update

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 12
Page: 1832-1845
Authors: A. Napolitano, P. Manini and M. d'Ischia

Diverse Facets of COMT: From a Plausible Predictive Marker to a Potential Drug Target for Schizophrenia

Journal: Current Molecular Medicine
Volume: 11,Issue: 9
Page: 732-743
Authors: M. Gupta, H. Kaur, A. Jajodia, S. Jain, K. Satyamoorthy, M. Mukerji, J. Thirthalli and R. Kukreti

L-Dopa Prodrugs: An Overview of Trends for Improving Parkinsons Disease Treatment

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 32
Page: 3482-3493
Authors: Antonio Di Stefano, Piera Sozio, Laura Serafina Cerasa and Antonio Iannitelli

Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 91-99
Authors: R. B. Mythri and M. M. Srinivas Bharath

Challenge and Therapeutic Studies Using Alpha-Methyl-para-Tyrosine (AMPT) in Neuropsychiatric Disorders: A Review

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 8,Issue: 4
Page: 249-256
Authors: Oswald J.N. Bloemen, M. B. de Koning, E. Boot, J. Booij and T.A. M.J. van Amelsvoort

Targeting Catechol-O-Methyl Transferase (COMT) Inhibitors for Schizophrenia:An Approach to Target Validation and Rational Drug Design

Journal: Letters in Drug Design & Discovery
Volume: 8,Issue: 3
Page: 246-252
Authors: Deepak Purushotham, Chaiti Ganguly and Chiranjib Chakraborty

Folate Status and Depressive Symptoms in Reproductive-Age Women

Journal: Current Nutrition & Food Science
Volume: 7,Issue: 2
Page: 96-102
Authors: Hiroko Watanabe, Takashi Sugiyama, Hiromitsu Chihara and Hideoki Fukuoka

Pituitary Microadenoma Treated with Antipsychotic Drug Aripiprazole

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 5,Issue: 1
Page: 58-60
Authors: Richard J. Wix-Ramos, Reinalis Paez, Eduardo Capote and Uribe Ezequiel

Direct and Indirect Modulation of the N-Methyl D-Aspartate Receptor: Potential for the Development of Novel Antipsychotic Therapies

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 1,Issue: 1
Page: 1-16
Authors: M. J. Marino and P. Jeffrey Conn

Disulfiram: An Old Therapeutic with New Applications

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 1
Page: 5-12
Authors: Kelly S. Barth and Robert J. Malcolm

Catechol-O-Methyltransferase (COMT) Pharmacogenetics in the Treatment Response Phenotypes of Major Depressive Disorder (MDD)

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 264-272
Authors: Neslihan Aygun Kocabas

Tyrosine Hydroxylase Gene: Another Piece of the Genetic Puzzle of Parkinson’s Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 469-481
Authors: Guney Bademci, Jeffery M. Vance and Liyong Wang

Neurotransmitters, Psychotropic Drugs and Microglia: Clinical Implications for Psychiatry

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 331-344
Authors: T. A. Kato, Y. Yamauchi, H. Horikawa, A. Monji, Y. Mizoguchi, Y. Seki, K. Hayakawa, H. Utsumi and S. Kanba

Recent Developments in Neurochemical Imaging in Schizophrenia: An Update

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 351-356
Authors: Nora S. Vyas, Neva H. Patel, Peter Herscovitch, Basant K. Puri and Rupert Lanzenberger

Neurochemistry of Schizophrenia: The Contribution of Neuroimaging Postmortem Pathology and Neurochemistry in Schizophrenia

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 21
Page: 2375-2392
Authors: B. Dean

Receptor Heteromers in Parkinson’s Disease and L-DOPA-Induced Dyskinesia

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 8
Page: 1101-1113
Authors: Chiara Fiorentini, Paola Savoia, Daria Savoldi and Cristina Missale

Differential Adaptive Changes in Dopaminergic System by Acute vs. Subchronic Ketamine: Relevance for Psychosis Pathophysiology and Treatment

Journal: Current Signal Transduction Therapy
Volume: 8,Issue: 2
Page: 119-128
Authors: Felice Iasevoli, Livia Avvisati, Gianmarco Latte, Elisabetta F. Buonaguro, Carmine Tomasetti, Luigi Aloj and Andrea de Bartolomeis

Synthesis and Pain Perception of New Analogues of Phencyclidine in NMRI Male Mice

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 14,Issue: 1
Page: 64-71
Authors: Abbas Ahmadi, Mohsen Khalili, Sara Marami, Afsane Ghadiri and Babak Nahri-Niknafs

In Silico Approach to Inhibition of Tyrosinase by Ascorbic Acid Using Molecular Docking Simulations

Journal: Current Topics in Medicinal Chemistry
Volume: 14,Issue: 12
Page: 1469-1472
Authors: F. Sezer Senol, M. Tareq Hassan Khan, Gurdal Orhan, Erdem Gurkas, Ilkay Erdogan Orhan, Nese Subutay Oztekin and Fikri Ak

Pharmacogenomics in Psychiatry: Implications for Practice

Journal: Recent Patents on Biotechnology
Volume: 8,Issue: 2
Page: 152-159
Authors: Thea R. Moore, Angela M. Hill and Siva K. Panguluri

From Ancient Chinese Medicine to a Novel Approach to Treat Cocaine Addiction

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 6
Page: 716-726
Authors: Ivan Diamond and Lina Yao

Aminochrome as New Preclinical Model to Find New Pharmacological Treatment that Stop the Development of Parkinson’s Disease

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 4
Page: 346-359
Authors: Juan Segura-Aguilar, Patricia Muñoz and Irmgard Paris

Development of Monoamine Oxidase B Inhibitors with Antiparkinson Activity

Journal: Current Physical Chemistry
Volume: 6,Issue: 1
Page: 40-52
Authors: Lucilene R. de Souza, Rafael de Matos Picanço, Abraão A. Pinheiro, Karina R. da Silva, Carlton A. Taft, Carlos H. T. de Paula da Silva, Cleydson B. R. dos Santos and Lorane I. da Silva Hage-Melim

Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing- Remitting Multiple Sclerosis

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 31
Page: 4876-4880
Authors: Begona M. Escribano, Macarena Aguilar-Luque, Carmen Bahamonde, Cristina Conde, Rafael Lillo, Fernando Sanchez-Lopez, Ana I. Giraldo, Antonio H. Cruz, Evelio Luque, Felix Gascon, Eduardo Aguera and Isaac Tunez

Ibopamine Stimulates α-Adrenergic Receptors and D1 Dopaminergic Receptors in the Eye

Journal: Current Drug Therapy
Volume: 2,Issue: 2
Page: 127-132
Authors: Italo Giuffre


Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 5
Page: 502-515
Authors: Xavier Lopez-Gil, Francesc Artigas and Albert Adell

Inflammation and Mood Disorders: Proinflammatory Cytokines and the Pathogenesis of Depression

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 9,Issue: 3
Page: 212-220
Authors: M. Beatriz Currier and Charles B. Nemeroff

Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 9
Page: 1380-1404
Authors: J. K. Shin, D. T. Malone, I. T. Crosby and B. Capuano

Inotropic Therapies in Asphyxiated Neonates: The Clinical and Laboratory Facts

Journal: Current Pediatric Reviews
Volume: 5,Issue: 2
Page: 71-78
Authors: Chloe Joynt and Po-Yin Cheung

Dopexamine After Heart Surgery: An Uncommonly Used, Though Useful Inotropic Agent

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 5,Issue: 1
Page: 66-68
Authors: Georgios I. Tagarakis, Georgios E. Stylianakis and Nikolaos B. Tsilimingas

Could Sigma Receptor Ligands be a Treatment for Methamphetamine Addiction?

Journal: Current Drug Abuse Reviews
Volume: 3,Issue: 3
Page: 156-162
Authors: Kelli R. Rodvelt and Dennis K. Miller

Imaging Endogenous Neurotransmitters In Vivo with Positron Emission Tomography Displacement Studies

Journal: Current Psychopharmacology
Volume: 1,Issue: 1
Page: 29-43
Authors: Giampaolo Tomasi

Alterations of Brain Membranes in Schizophrenia: Impact of Phospholipase A2

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 21
Page: 2314-2323
Authors: E.L. Schaeffer, W.F. Gattaz and G.P. Eckert

Role of Descending Aminergic Pathways in the Development of Locomotion

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 24
Page: 4332-4340
Authors: Edouard Pearlstein

GnRH-Agonist Triggering to Avoid Ovarian Hyperstimulation Syndrome: A Review of the Evidence

Journal: Current Drug Targets
Volume: 14,Issue: 8
Page: 843-849
Authors: Maria Cerrillo Martinez, Francisco J. Ruiz and Juan A. García-Velasco

Roles of Renal Proximal Tubule Transport in the Pathogenesis of Hypertension

Journal: Current Hypertension Reviews
Volume: 9,Issue: 2
Page: 148-155
Authors: Shoko Horita, George Seki, Hideomi Yamada, Masashi Suzuki, Kazuhiko Koike and Toshiro Fujita

Molecular Imaging of Neuropsychiatry and Boron Neutron Capture Therapy in Neuro-oncology

Journal: Current Molecular Imaging (Discontinued)
Volume: 3,Issue: 1
Page: 15-26
Authors: Chun-Kai Fang, Ya-Fang Chang, Hui-Yen Chuang, Hong-Wen Chen and Jeng-Jong Hwang

Towards Next Generation Adenosine A2A Receptor Antagonists

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 34
Page: 3918-3935
Authors: G. Yuan and G.B. Jones

The Neuroprotective Role of Vesicular Monoamine Transporter 2 in Neurodegenerative Diseases

Journal: Medicinal Chemistry
Volume: 11,Issue: 2
Page: 104-108
Authors: Burak Yulug, Lutfu Hanoglu and Ertugrul Kilic

Recent Progress of Imaging Agents for Parkinson’s Disease

Journal: Current Neuropharmacology
Volume: 12,Issue: 6
Page: 551-563
Authors: Xiaoai Wu, Huawei Cai, Ran Ge, Lin Li and Zhiyun Jia

The Role of the Catechol-o-Methyltransferase (COMT) GeneVal158Met in Aggressive Behavior, a Review of Genetic Studies

Journal: Current Neuropharmacology
Volume: 13,Issue: 6
Page: 802-814
Authors: Arqam Qayyum, Clement C. Zai, Yuko Hirata, Arun K. Tiwari, Sheraz Cheema, Behdin Nowrouzi, Joseph H. Beitchman and L. Kennedy

Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 2
Page: 238-246
Authors: Amir Sarrafchi, Mahmoud Bahmani, Hedayatollah Shirzad and Mahmoud Rafieian-Kopaei

Comparable Neuroprotective Effects of Pergolide and Pramipexole on Ferrous Sulfate-Induced Dopaminergic Cell Death in Cell Culture

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15,Issue: 10
Page: 1325-1332
Authors: Doreen Reichelt, Khaled Radad, Rudolf Moldzio, Wolf-Dieter Rausch, Heinz Reichmann and Gabriele Gille

Neurobiological and Molecular Bases of Methamphetamine-Induced Behavioral Sensitization and Spontaneous Recurrence of Methamphetamine Psychosis, and its Implication in Schizophrenia

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 3
Page: 381-393
Authors: Kunio Yui, Yasushi Kajii and Toru Nishikawa

Aminergic Control and Modulation of Honeybee Behaviour

Journal: Current Neuropharmacology
Volume: 4,Issue: 4
Page: 259-276
Authors: R. Scheiner, A. Baumann and W. Blenau

Central Oxytocinergic Neurotransmission: A Drug Target for the Therapy of Psychogenic Erectile Dysfunction

Journal: Current Drug Targets
Volume: 4,Issue: 1
Page: 55-66
Authors: M. R. Melis and A. Argiolas

Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 15
Page: 1512-1524
Authors: Rodrigo A. Cunha, Sergi Ferre, Jean-Marie Vaugeois and Jiang-Fan Chen

Targeting the Progression of Parkinsons Disease

Journal: Current Neuropharmacology
Volume: 7,Issue: 1
Page: 9-36
Authors: J. L. George, S. Mok, D. Moses, S. Wilkins, A. I. Bush, R. A. Cherny and D. I. Finkelstein

May Exercise Prevent Addiction?

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 45-48
Authors: C. A. Fontes-Ribeiro, E. Marques, F. C. Pereira, A. P. Silva and T. R. A. Macedo

Anti-Inflammatory Properties of Antipsychotics Via Microglia Modulations: Are Antipsychotics a ‘Fire Extinguisher’ in the Brain of Schizophrenia?

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11,Issue: 7
Page: 565-574
Authors: T. A. Kato, A. Monji, Y. Mizoguchi, S. Hashioka, H. Horikawa, Y. Seki, M. Kasai, H. Utsumi and S. Kanba

CART Peptides as Targets for CNS Drug Development

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 2,Issue: 3
Page: 201-205
Authors: Richard G. Hunter and Michael J. Kuhar

Treatment of Schizophrenia and Comorbid Substance Use Disorder

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 1,Issue: 2
Page: 129-139
Authors: Alan I. Green, Melinda S. Salomon, Mark J. Brenner and Kimberly Rawlins

Drugs Used to Treat Parkinsons Disease, Present Status and Future Directions

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 4
Page: 321-342
Authors: Omar M.E. Abdel-Salam

Aripiprazole: A Drug with a Novel Mechanism of Action and Possible Efficacy for Alcohol Dependence

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 1
Page: 50-54
Authors: Derick E. Vergne and Raymond F. Anton

Overview of Tyrosine Hydroxylase in Parkinson’s Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 350-358
Authors: Yanzhen Zhu, Jing Zhang and Yanjun Zeng

Elicitation of Dopaminergic Features of Parkinson’s Disease in C. elegans by Monocrotophos, an Organophosphorous Insecticide

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 8
Page: 993-1000
Authors: Shaheen Jafri Ali and Padmanabhan Sharda Rajini

Clinical Management of the Cardiovascular Failure in Sepsis

Journal: Current Vascular Pharmacology
Volume: 11,Issue: 2
Page: 222-242
Authors: Daniel De Backer and Sabino Scolletta

Does Parkinson’s Disease and Type-2 Diabetes Mellitus Present Common Pathophysiological Mechanisms and Treatments?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 3
Page: 418-428
Authors: Marcelo M.S. Lima, Adriano D.S. Targa, Ana C.D. Noseda, Lais S. Rodrigues, Ana Marcia Delattre, Fabiola V. dos Santos, Mariana H. Fortes, Maira J. Maturana and Anete C. Ferraz

Alcohol Abuse and HIV Infection: Role of DRD2

Journal: Current HIV Research
Volume: 12,Issue: 4
Page: 234-242
Authors: Marisela Agudelo, Pradnya Khatavkar, Adriana Yndart, Changwon Yoo, Rhonda Rosenberg, Jessy G. Devieux, Robert M. Malow and Madhavan Nair

Oleic Acid Protects Against Oxidative Stress Exacerbated by Cytarabine and Doxorubicin in Rat Brain

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 11
Page: 1491-1495
Authors: David Calderón Guzmán, Norma Osnaya Brizuela, Maribel Ortíz Herrera, Hugo Juárez Olguín, Ernestina Hernández García, Armando Valenzuela Peraza and Gerardo Barragán Mejía

Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape

Journal: Current Neuropharmacology
Volume: 15,Issue: 1
Page: 184-194
Authors: Kenneth Blum, Marcelo Febo, Rajendra D. Badgaiyan, Zsolt Demetrovics, Thomas Simpatico, Claudia Fahlke, Oscar-Berman M., Mona Li, Kristina Dushaj and Mark S. Gold

Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs

Journal: Current Drug Therapy
Volume: 10,Issue: 2
Page: 66-81
Authors: Felix-Martin Werner and Rafael Coveñas

Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 42
Page: 6366-6379
Authors: Aviv Weinstein, Abigail Livny and Abraham Weizman

Benzo- and Thienobenzo- Diazepines: Multi-target Drugs for CNS Disorders

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 15,Issue: 8
Page: 630-647
Authors: F.J.B. Mendonca Junior, L. Scotti, H. Ishiki, S.P.S. Botelho, M.S. Da Silva and M.T. Scotti

Stimulating Effects of H1-Antagonists

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 20
Page: 2501-2509
Authors: Eef L. Theunissen, Annemiek Vermeeren, Eric F.P.M. Vuurman and Johannes G. Ramaekers

Understanding Gender Differences in Schizophrenia: A Review of the Literature

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 2
Page: 255-265
Authors: Rachel Taylor and Robyn Langdon

Neuropeptide Y: Role in Emotion and Alcohol Dependence

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 2
Page: 181-195
Authors: R. Quirion, Y. Dumont and C. Carvajal

Modulation of Eating by Central Catecholamine Systems

Journal: Current Drug Targets
Volume: 6,Issue: 2
Page: 191-199
Authors: Paul J. Wellman

Cellular Mechanisms of Striatum-Dependent Behavioral Plasticity and Drug Addiction

Journal: Current Molecular Medicine
Volume: 2,Issue: 7
Page: 649-665
Authors: Stephania Fasano and Riccardo Brambilla

The Neuropharmacology of (-)-Stepholidine and its Potential Applications

Journal: Current Neuropharmacology
Volume: 5,Issue: 4
Page: 289-294
Authors: Kechun Yang, Guozhang Jin and Jie Wu

Nonsteroidal Anti-Inflammatory Drugs in Experimental Parkinsonian Models and Parkinsons Disease

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 14
Page: 1428-1434
Authors: Masato Asanuma and Ikuko Miyazaki

Chronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover

Journal: Current Drug Metabolism
Volume: 9,Issue: 7
Page: 622-627
Authors: G. Neurauter, K. Schrocksnadel, S. Scholl-Burgi, B. Sperner-Unterweger, C. Schubert, M. Ledochowski and D. Fuchs

Iron Chelators as Potential Therapeutic Agents for Parkinsons Disease

Journal: Current Bioactive Compounds
Volume: 4,Issue: 3
Page: 150-158
Authors: Carlos A. Perez, Yong Tong and Maolin Guo

Potential Novel Anxiolytic Drugs

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 33
Page: 3534-3546
Authors: D. Christmas, S. Hood and D. Nutt


Brain Norepinephrine System as a Target for Antidepressant and Mood Stabilizing Medications

Journal: Current Drug Targets
Volume: 10,Issue: 11
Page: 1061-1068
Authors: Eliyahu Dremencov, Mostafa el Mansari and Pierre Blier

Endogenous Cannabinoid and Opioid Systems and their Role in Nicotine Addiction

Journal: Current Drug Targets
Volume: 11,Issue: 4
Page: 440-449
Authors: Rafael Maldonado and Fernando Berrendero

Restless Leg Syndrome Associated with Olanzapine: A Case Series

Journal: Current Drug Safety
Volume: 5,Issue: 2
Page: 129-131
Authors: Shilpa Aggarwal, Seetal Dodd and Michael Berk

Current Opinions and Perspectives on the Role of Immune System in the Pathogenesis of Parkinson's Disease

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 2
Page: 200-208
Authors: Maria Antonietta Panaro and Antonia Cianciulli

Drugs and Aggression

Journal: Recent Patents on CNS Drug Discovery
Volume: 3,Issue: 1
Page: 40-49
Authors: Alberto A. Rasia-Filho, Marcia Giovenardi and Rosa M.M. de Almeida

Prevention and Management of Ovarian Hyperstimulation Syndrome

Journal: Current Women`s Health Reviews
Volume: 6,Issue: 2
Page: 130-145
Authors: Botros Rizk and Christopher B. Rizk

Role of Neural Stem Cells in Parkinsons Disease

Journal: Current Signal Transduction Therapy
Volume: 6,Issue: 3
Page: 337-340
Authors: Rebeca Millan-Guerrero

The Neuropsychopharmacology of Pathological Gambling

Journal: Current Psychiatry Reviews
Volume: 8,Issue: 1
Page: 20-24
Authors: Kourosh Zakeri and Marc N. Potenza

Cytokine-Purine Interactions in Traumatic Stress, Behavioral Depression,and Sickness

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 5
Page: 547-560
Authors: Thomas R. Minor, Qingjun Huang and Alexis E. Witt

Novel Targets for Drugs in Schizophrenia

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6,Issue: 4
Page: 265-272
Authors: J.M. Stone and L.S. Pilowsky

Antipsychotic Drugs: Evolving Mechanisms of Action with Improved Therapeutic Benefits

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 3,Issue: 3
Page: 217-226
Authors: B. Dean and E. Scarr

Pharmacological Findings Contribute to the Understanding of the Main Physiological Mechanisms of Memory Retrieval

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 2,Issue: 2
Page: 81-94
Authors: Daniela M. Barros, Luciana A. Izquierdo, Jorge H. Medina and Ivan Izquierdo

Ionotropic Glutamate Receptors as Therapeutic Targets in Schizophrenia

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 1,Issue: 2
Page: 183-189
Authors: Joseph T. Coyle, Guochuan Tsai and Donald C. Goff

“Speed” Warps Time: Methamphetamines Interactive Roles in Drug Abuse, Habit Formation, and the Biological Clocks of Circadian and Interval Timing

Journal: Current Drug Abuse Reviews
Volume: 1,Issue: 2
Page: 203-212
Authors: Lauren L. Williamson, Ruey-Kuang Cheng, Mikel Etchegaray and Warren H. Meck

Can Increased Food Intake Improve Psychosis? A Brief Review and Hypothesis

Journal: Current Molecular Pharmacology
Volume: 1,Issue: 3
Page: 270-272
Authors: T. Treuer, J. Karagianis and V. P. Hoffmann

Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 5
Page: 442-453
Authors: T. S. Shippenberg, A. LeFevour and V. I. Chefer

Novel Anti-Inflammatory and Neuroprotective Agents for Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 2
Page: 232-240
Authors: Li Lu, Fengqiao Li and Xiaomin Wang

The Progress of Selective Fluorescent Chemosensors by Boronic Acid

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 16
Page: 2621-2637
Authors: S. Huang, M. Jia, Y. Xie, J. Wang, W. Xu and H. Fang

Treating Impaired Cognition in Schizophrenia

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 8
Page: 1587-1594
Authors: H. M. Ibrahim and C. A. Tamminga

A Brief Overview of Tyrosine Hydroxylase and α-Synuclein in the Parkinsonian Brain

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 456-462
Authors: Wajihullah Khan, Medha Priyadarshini, Haytham A. Zakai, Mohammad A. Kamal and Qamre Alam

Gene-Environment Interactions Underlying the Effect of Cannabis in First Episode Psychosis

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 32
Page: 5024-5035
Authors: Jose Maria Pelayo-Teran, Paula Suarez-Pinilla, Nicholas Chadi and Benedicto Crespo-Facorro

Cocaine Toxicity and Hepatic Oxidative Stress

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 33
Page: 5677-5682
Authors: V. Vitcheva

Facilitative Effect of Serotonin1A Receptor Agonists on Cognition in Patients with Schizophrenia

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 357-362
Authors: T. Sumiyoshi and Y. Higuchi

The Effects of Locus Coeruleus and Norepinephrine in Methamphetamine Toxicity

Journal: Current Neuropharmacology
Volume: 11,Issue: 1
Page: 80-94
Authors: Michela Ferrucci, Filippo S. Giorgi, Alessia Bartalucci, Carla L. Busceti and Francesco Fornai

Psychoimmunological Analysis of Cancer Patients: Correlation with the Prognosis

Journal: Current Aging Science
Volume: 5,Issue: 3
Page: 263-272
Authors: Giuseppina Messina, Paolo Lissoni and Franco Rovelli

Drug-Induced Hypothermia in Stroke Models: Does it Always Protect?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 3
Page: 371-380
Authors: Meijuan Zhang, Haiying Wang, Jinbing Zhao, Cong Chen, Rehana K. Leak, Yun Xu, Peter Vosler, Jun Chen, Yanqin Gao and Feng Zhang

Copper Modified Magnetic Bimetallic Nano-catalysts Ligand Regulated Catalytic Activity

Journal: Current Organic Chemistry
Volume: 17,Issue: 20
Page: 2227-2237
Authors: Nasir B. R. Baig and Rajender S. Varma

Motor Complications in Parkinson’s Disease: A Comprehensive Review of Emergent Management Strategies

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 7
Page: 1017-1049
Authors: Susana Marques de Sousa and João Massano

Classical Neurotransmitters and Neuropeptides Involved in Major Depression in a Multi-neurotransmitter System: A Focus on Antidepressant Drugs

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 38
Page: 4853-4858
Authors: Felix-Martin Werner and R. Coveñas

Restless Leg Syndrome Associated with Atypical Antipsychotics: Current Status, Pathophysiology, and Clinical Implications

Journal: Current Drug Safety
Volume: 10,Issue: 2
Page: 98-105
Authors: Shilpa Aggarwal, Seetal Dodd and Michael Berk

Potential Targets for the Development of Novel Antidepressants: Future Perspectives

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 2
Page: 270-281
Authors: Vishnu N. Thakare and Bhoomika M. Patel

Sulfation of Phenylephrine by the Human Cytosolic Sulfotransferases

Journal: Drug Metabolism Letters
Volume: 8,Issue: 2
Page: 96-100
Authors: Akihiro Yamamoto, Jiwan Kim, Ming-Yih Liu, Katsuhisa Kurogi, Yoichi Sakakibara, Masahito Suiko and Ming-Cheh Liu

Early-Life Stress and Psychiatric Disorders: Epidemiology, Neurobiology and Innovative Pharmacological Targets

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 11
Page: 1379-1387
Authors: A. Ventriglio, A. Gentile, R.J. Baldessarini and A. Bellomo

Salvinorin A and Related Compounds as Therapeutic Drugs for Psychostimulant-Related Disorders

Journal: Current Drug Abuse Reviews
Volume: 7,Issue: 2
Page: 128-132
Authors: R.G. dos Santos, J.A.S. Crippa, J.P. Machado-de-Sousa and J.E.C. Hallak

Nitric Oxide-GAPDH Transcriptional Signaling Mediates Behavioral Actions of Cocaine

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 6
Page: 757-763
Authors: Maged M. Harraz and Solomon H. Snyder

Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series

Journal: Current Drug Safety
Volume: 11,Issue: 1
Page: 102-103
Authors: Suravi Patra

Aporphines and Parkinson’s Disease: Medical Tools for the Future

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 17
Page: 1906-1909
Authors: Seyed Fazel Nabavi, Eugenio Uriarte, Luca Rastrelli, Brenda Modak and Eduardo Sobarzo-Sánchez

Psychopharmacology of Attention-Deficit Hyperactivity Disorder: Effects and Side Effects

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 5
Page: 590-594
Authors: Javad Golmirzaei, Hamidreza Mahboobi, Maryam Yazdanparast, Gohar Mushtaq, Mohammad A. Kamal and Enayatollah Hamzei

Monoamine Oxidase Inhibitors: Perspective Design for the Treatment of Depression and Neurological Disorders

Journal: Current Enzyme Inhibition
Volume: 12,Issue: 2
Page: 115-122
Authors: Bijo Mathew, Githa E. Mathew, Jerad Suresh, Gülberk Ucar, Rani Sasidharan, Sockalingam Anbazhagan, Jobin K. Vilapurathu and Venkatesan Jayaprakash

The Brain Protective Effect of rTMS (Repetitive Transcranial Magnetic Stimulation) in Depression: A Mini-Review in Animal Studies

Journal: Medicinal Chemistry
Volume: 12,Issue: 6
Page: 500-505
Authors: Burak Yulug, Lütfü Hanoglu, Ahmet M. Tavli, Nesrin H. Yılmaz and Ertugrul Kılıc

Influence of Physical Immobilization of dsDNA on Carbon Based Matrices of Electrochemical Sensors

Journal: Current Pharmaceutical Analysis
Volume: 10,Issue: 1
Page: 20-29
Authors: Livia Alexandra Gugoasa, Raluca-Ioana Stefan-van Staden, Anton Alexandru Ciucu and Jacobus Frederick van Staden

Fluparoxan: A Comprehensive Review of its Discovery, Adrenergic and CNS Activity and Treatment of Cognitive Dysfunction in Central Neurodegenerative Diseases

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17,Issue: 7
Page: 572-582
Authors: Alan D. Borthwick

Sulfation in Dog

Journal: Current Drug Metabolism
Volume: 6,Issue: 3
Page: 275-285
Authors: C. Tsoi and S. Swedmark

Pharmacological Aspects of (-)-Deprenyl

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 15
Page: 2017-2031
Authors: K. Magyar, M. Palfi, T. Tabi, H. Kalasz, B. Szende and E. Szoko

Neurokinin Peptides and Neurokinin Receptors as Potential Therapeutic Intervention Targets of Basal Ganglia in the Prevention and Treatment of Parkinsons Disease

Journal: Current Drug Targets
Volume: 5,Issue: 2
Page: 197-206
Authors: L.- W. Chen, K. K.L. Yung and Y S Chan

Gene Therapy for Neurological Disorders: Challenges and Future Prospects for the Use of Growth Factors for the Treatment of Parkinsons Disease

Journal: Current Gene Therapy
Volume: 9,Issue: 5
Page: 375-388
Authors: Fredric p. Manfredsson, Michael S. Okun and Ronald J. Mandel

Conditioned Avoidance Response in the Development of New Antipsychotics

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 3
Page: 358-370
Authors: M-L. G. Wadenberg

Identification of Molecular Targets Associated with Ethanol Toxicity and Implications in Drug Development

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 11
Page: 1313-1355
Authors: Lin-Lin Wang, An-Kui Yang, Shu-Ming He, Jun Liang, Zhi-Wei Zhou, Yong Li and Shu-Feng Zhou

FMRI, Antipsychotics and Schizophrenia. Influence of Different Antipsychotics on BOLD-Signal

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 18
Page: 2012-2025
Authors: Christian H. Roder, Janna Marie Hoogendam and Frederik M. van der Veen

Reward Circuitry Dopaminergic Activation Regulates Food and Drug Craving Behavior

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 12
Page: 1158-1167
Authors: Kenneth Blum, Yijun Liu, Richard Shriner and Mark S. Gold

Diagnostic and Pathophysiological Impact of FP-CIT SPECT in Parkinson s Disease

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 7,Issue: 3
Page: 173-176
Authors: Jorg Spiegel

Neurotransmitter and Imaging Studies in Anorexia Nervosa: New Targets for Treatment

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 2,Issue: 1
Page: 61-72
Authors: Nicole C. Barbarich, Walter H. Kaye and David Jimerson

Glutamate and Schizophrenia: Pathophysiology and Therapeutics

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 2,Issue: 1
Page: 29-44
Authors: G. J. Marek

Glutamate Receptors as Therapeutic Targets for Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8,Issue: 6
Page: 475-491
Authors: Kari A. Johnson, P. Jeffrey Conn and Colleen M. Niswender

Moving Beyond Tyrosine Hydroxylase to Define Dopaminergic Neurons for Use in Cell Replacement Therapies for Parkinson’s Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 340-349
Authors: Robert B. White and Meghan G. Thomas

Anti-Aggressive, Brain Neurotransmitters and Receptor Binding Study of Fumaria indica in Rodents

Journal: Current Psychopharmacology
Volume: 1,Issue: 3
Page: 195-202
Authors: Gireesh Kumar Singh, Geeta Rai, Shyam Sunder Chatterjee and Vikas Kumar

Quetiapine Induced Hypomania: A Case Report and a Review of the Literature

Journal: Current Drug Safety
Volume: 7,Issue: 3
Page: 250-253
Authors: R. Bou Khalil and C. Baddoura

Computational Approaches to Screen Candidate Ligands with Anti- Parkinson’s Activity Using R Programming

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 16
Page: 1807-1814
Authors: R.M. Jayadeepa and M.S. Niveditha

Neurotransmitters and Microglial-Mediated Neuroinflammation

Journal: Current Protein & Peptide Science
Volume: 14,Issue: 1
Page: 21-32
Authors: Moonhee Lee

Serotonergic Drugs for Depression and Beyond

Journal: Current Drug Targets
Volume: 14,Issue: 5
Page: 578-585
Authors: Stephen M. Stahl, Clara Lee-Zimmerman, Sylvia Cartwright and Debbi Ann Morrissette

Blockade of MK-801-Induced Heat Shock Protein 72/73 in Rat Brain by Antipsychotic and Monoaminergic Agents Targeting D2, 5-HT1A, 5-HT2A and α1-Adrenergic Receptors

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 1
Page: 104-111
Authors: Tamara Romon, Anna M. Planas and Albert Adell

Immobilization-Induced Behavioral Deficits are Attenuated But Coping with Repeated Stress Impaired in Apomorphine Injected Rats

Journal: Current Psychopharmacology
Volume: 2,Issue: 3
Page: 254-259
Authors: Darakhshan Jabeen Haleem and Huma Ikram

Adenosine A2A-D2 Receptor-Receptor Interactions in Putative Heteromers in the Regulation of the Striato-Pallidal GABA Pathway: Possible Relevance for Parkinson`s Disease and its Treatment

Journal: Current Protein & Peptide Science
Volume: 15,Issue: 7
Page: 673-680
Authors: Sarah Beggiato, Tiziana Antonelli, Maria C. Tomasini, Andrea C. Borelli, Luigi F. Agnati, Sergio Tanganelli, Kjell Fuxe and Luca Ferraro

Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 23
Page: 3359-3366
Authors: Nicolas Simon, Benjamin Rolland and Laurent Karila

Chronic Effects of Cocaine on Dopaminergic and Serotonergic Systems of Rats

Journal: Current Molecular Imaging (Discontinued)
Volume: 4,Issue: 1
Page: 43-52
Authors: Chun-Kai Fang, Hui-Yen Chuang, Wei-Hsun Wang, Ren-Shyun Liu, Shyh-Jen Wang and Jeng-Jong Hwang

Parkinson’s Disease: Recent Updates in the Identification of Human Dopa Decarboxylase Inhibitors

Journal: Current Drug Metabolism
Volume: 17,Issue: 5
Page: 513-518
Authors: Riccardo Montioli, Carla B. Voltattorni and Mariarita Bertoldi

The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment

Journal: Current Neuropharmacology
Volume: 12,Issue: 3
Page: 219-238
Authors: Felice Iasevoli, Carmine Tomasetti, Elisabetta F. Buonaguro and Andrea de Bartolomeis

Pharmacological Support of Neurorehabilitation

Journal: Current Drug Therapy
Volume: 1,Issue: 1
Page: 17-22
Authors: Burkhard Pleger and Patrick Ragert

Transgenic Mouse Studies Reveal Substantial Roles for Opioid Receptors in the Rewarding Effects of Several Classes of Addictive Drugs

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 1
Page: 27-37
Authors: F. S. Hall and George R. Uhl

An Inflammatory Pathomechanism for Parkinsons Disease?

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 5
Page: 591-602
Authors: Christophe Wersinger and Anita Sidhu

Catecholamines: Physiological Immunomodulators During Health and Illness

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 17
Page: 1979-1989
Authors: Reiner Oberbeck

Novel Micropelletization Technique: Highly Improved Dissolution, Wettability and Micromeritic Behavior of Domperidone

Journal: Current Drug Delivery
Volume: 3,Issue: 3
Page: 307-313
Authors: L. Prabakaran and Meenakshi Bajpai

NSAID Use and the Risk of Parkinsons Disease

Journal: Current Drug Safety
Volume: 1,Issue: 3
Page: 223-225
Authors: Mahyar Etminan and Samy Suissa

Tianeptine: A Novel Atypical Antidepressant that May Provide New Insights into the Biomolecular Basis of Depression

Journal: Recent Patents on CNS Drug Discovery
Volume: 1,Issue: 1
Page: 29-41
Authors: Christiaan B. Brink, Brian H. Harvey and Linda Brand

Recent Patents on Pharmacotherapy for Alcoholism

Journal: Recent Patents on CNS Drug Discovery
Volume: 1,Issue: 2
Page: 175-206
Authors: Jozsef Nagy

Non-Classical Drug Metabolism Enzymes: The Curious Case of Phenylalanine 4-Monooxygenase

Journal: Letters in Drug Design & Discovery
Volume: 3,Issue: 6
Page: 405-412
Authors: G. B. Steventon and S. C. Mitchell

Neonatal Environment and Neuroendocrine Programming of the Peripheral Respiratory Control System

Journal: Current Pediatric Reviews
Volume: 2,Issue: 3
Page: 199-208
Authors: Aida Bairam, Richard Kinkead and Vincent Joseph

Galanin: A Novel Therapeutic Target for Depression, Anxiety Disorders and Drug Addiction?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5,Issue: 2
Page: 225-232
Authors: A. Holmes and M. R. Picciotto

Neurochemistry of the Nucleus Accumbens and its Relevance to Depression and Antidepressant Action in Rodents

Journal: Current Neuropharmacology
Volume: 4,Issue: 4
Page: 277-291
Authors: Yukihiko Shirayama and Shigeyuki Chaki


Computer Prediction of Cardiovascular and Hematological Agents by Statistical Learning Methods

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5,Issue: 1
Page: 11-19
Authors: X. Chen, H. Li, C. W. Yap, C. Y. Ung, L. Jiang, Z. W. Cao, Y. X. Li and Y. Z. Chen

Prevention of Contrast Induced Nephropathy

Journal: Current Drug Therapy
Volume: 2,Issue: 1
Page: 3-9
Authors: Jeffrey W.H. Fung, Cheuk C. Szeto, Leo C.C. Kum and Cheuk M. Yu

Current Advances in the Treatment of Parkinsons Disease with Stem Cells

Journal: Current Neurovascular Research
Volume: 4,Issue: 2
Page: 99-109
Authors: Katarzyna A. Trzaska and Pranela Rameshwar

Parkinsons Disease: Genetics and Beyond

Journal: Current Neuropharmacology
Volume: 5,Issue: 2
Page: 99-113
Authors: N. N. Inamdar, D. K. Arulmozhi, A. Tandon and S. L. Bodhankar

Gene Therapy for Parkinsons Disease: Progress and Challenges

Journal: Current Gene Therapy
Volume: 5,Issue: 1
Page: 71-80
Authors: Qin Chen, Yi He and Keyi Yang

Magnetic Resonance Imaging of Iron in Parkinsons Disease

Journal: Current Medical Imaging Reviews
Volume: 1,Issue: 1
Page: 43-48
Authors: Kazuo Abe and Tachio Hikita

Inflammatory Process in Parkinsons Disease: Role for Cytokines

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 8
Page: 999-1016
Authors: T. Nagatsu and M. Sawada

A Review of Neuroprotective Agents

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 18
Page: 2383-2397
Authors: M. S. Levi and M. A. Brimble

Bivalent Ligands for G Protein-Coupled Receptors

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 17
Page: 2015-2020
Authors: William S. Messer and Jr.

The Abuse Liability and Therapeutic Potential of Drugs Evaluated for Cocaine Addiction as Predicted by Animal Models

Journal: Current Neuropharmacology
Volume: 1,Issue: 1
Page: 21-46
Authors: Joshua A. Lile and Michael A. Nader

Genetic Factors in Parkinsons Disease and Potential Therapeutic Targets

Journal: Current Neuropharmacology
Volume: 1,Issue: 4
Page: 301-313
Authors: Jian Feng

Serotonin Control of Dopaminergic Neurotransmission: Focus on 5-HT2 Receptors

Journal: Current Neuropharmacology
Volume: 1,Issue: 2
Page: 153-164
Authors: Vincenzo Di Matteo and Ennio Esposito

Possible Role of the Extracellular Signal-Regulated Kinase (ERK) in Reward-Controlled Learning and Addiction

Journal: Current Neuropharmacology
Volume: 1,Issue: 2
Page: 165-174
Authors: Emmanuel Valjent, Denis Herve, Jocelyne Caboche and Jean-Antoine Girault

The Effects of Speech Therapy and Pharmacological Treatments on Voice and Speech in Parkinsons Disease: A Review of the Literature

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 14
Page: 1359-1366
Authors: Geralyn M. Schulz

Molecular Mapping in the CNS

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 17
Page: 1547-1570
Authors: Margaret G. Wong, Benjamin G. Tehan and Edward J. Lloyd

Serotonin Receptor and Transporter Ligands - Current Status

Journal: Current Medicinal Chemistry
Volume: 8,Issue: 9
Page: 999-1034
Authors: Seung Jun Oh, Hyun-Joon Ha, Dae Yoon Chi and Hee Kyung Lee

Clozapine and Olanzapine but not Risperidone Impair the Pre-Frontal Striatal System in relation to Egocentric Spatial Orientation in a Y-Maze

Journal: Current Neurovascular Research
Volume: 4,Issue: 4
Page: 235-239
Authors: Cibele Canal Castro, Eleonora Araujo Dos Reis-Lunardelli, Werner J. Schmidt, Adriana Simon Coitinho and Ivan Izquierdo

The Endocannabinoid System in Parkinsons Disease

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 23
Page: 2337-2346
Authors: Massimiliano Di Filippo, Barbara Picconi, Alessandro Tozzi, Veronica Ghiglieri, Aroldo Rossi and Paolo Calabresi

Paliperidone: A Clinical Review

Journal: Current Drug Therapy
Volume: 4,Issue: 1
Page: 7-11
Authors: Ben Green

Neuro-Transmitters in the Central Nervous System & their Implication in Learning and Memory Processes

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 7
Page: 796-840
Authors: Helton J. Reis, Cristina Guatimosim, Maryse Paquet, Magda Santos, Fabiola M. Ribeiro, Arthur Kummer, Grace Schenatto, Joao V. Salgado, Luciene B. Vieira, Antonio L. Teixeira and Andras Palotas

A Role for Glutathione in the Pathophysiology of Bipolar Disorder and Schizophrenia? Animal Models and Relevance to Clinical Practice

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 23
Page: 2965-2976
Authors: O. M. Dean, M. van den Buuse, A.I. Bush, D.L. Copolov, F. Ng, S. Dodd and M. Berk

Imaging the Glutamate System in Humans: Relevance to Drug Discovery for Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 22
Page: 2594-2602
Authors: James M. Stone

The Pro-Apoptotic Substance Thapsigargin Selectively Stimulates Re-Growth of Brain Capillaries

Journal: Current Neurovascular Research
Volume: 6,Issue: 3
Page: 171-180
Authors: Celine Ullrich and Christian Humpel

Investigational Positive Inotropic Agents for Acute Heart Failure

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9,Issue: 3
Page: 193-205
Authors: Juan Tamargo, Ricardo Caballero, Ricardo Gomez, Adriana Barana, Irene Amoros and Eva Delpon

Neurotransmitter Effects in Human Immunodeficiency Virus (HIV) and Simian Immuno-Deficiency Virus (SIV) Infection

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 8,Issue: 2
Page: 153-163
Authors: E. Neuen-Jacob

Current and Future Therapeutic Strategies for Parkinsons Disease

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 34
Page: 3968-3976
Authors: Tiago Fleming Outeiro and Joaquim Ferreira

The Application of PET Technique for the Development and Evaluation of Novel Antipsychotics

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 3
Page: 371-377
Authors: Akihiro Takano

Real Time Analysis of Neurotransmitters in the Brain Using a Micro-Electrode System

Journal: Current Neurovascular Research
Volume: 7,Issue: 1
Page: 32-38
Authors: Suw Young Ly, Hwa Jin Heo and Min Jung Kim

Endocannabinoids as Regulators of Transient Receptor Potential (TRP)Channels: a Further Opportunity to Develop New Endocannabinoid-Based Therapeutic Drugs

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 14
Page: 1430-1449
Authors: V. Di Marzo and L. De Petrocellis

Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 14
Page: 1468-1486
Authors: Patricia H. Reggio

Neurochemistry Changes Associated with Mutations in Familial Parkinsons Disease

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 35
Page: 4378-4391
Authors: M. M. Siddique and E. K. Tan

PEGylated Liposomes Incorporated with Nonionic Surfactants as an Apomorphine Delivery System Targeting the Brain: In Vitro Release and In Vivo Real-time Imaging

Journal: Current Nanoscience
Volume: 7,Issue: 2
Page: 191-199
Authors: Shu-Hui Hsu, Saleh A. Al-Suwayeh, Chih-Chieh Chen, Chen-Hsien Chi and Jia-You Fang

Long-Term Protective Effects of Methamphetamine Preconditioning Against Single-Day Methamphetamine Toxic Challenges

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 35-39
Authors: A. B. Hodges, B. Ladenheim, M. T. McCoy, G. Beauvais, N. Cai, I. N. Krasnova and J. L. Cadet

Role of Sigma Receptors in Methamphetamine-Induced Neurotoxicity

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 54-57
Authors: Nidhi Kaushal and Rae R. Matsumoto

Methylone and Monoamine Transporters: Correlation with Toxicity

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 58-62
Authors: Chiharu Sogawa, Norio Sogawa, Kazumi Ohyama, Ruri Kikura-Hanajiri, Yukihiro Goda, Ichiro Sora and Shigeo Kitayama

Enhanced Hyperthermia Induced by MDMA in Parkin Knockout Mice

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 96-99
Authors: Y. Takamatsu, H. Shiotsuki, S. Kasai, S. Sato, T. Iwamura, N. Hattori and K. Ikeda

Gastrodia Elata Bl Attenuates Methamphetamine-Induced Dopaminergic Toxicity Via Inhibiting Oxidative Burdens

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 118-121
Authors: E.-J. Shin, J.-H. Bach, T.-T. L. Nguyen, X.-K. T. Nguyen, B.-D. Jung, K.-W. Oh, M. J. Kim, S. K. Ko, C. G. Jang, S. F. Ali and H.-C. Kim

Association Analysis of the Adenosine A1 Receptor Gene Polymorphisms in Patients with Methamphetamine Dependence/Psychosis

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 137-142
Authors: > Kobayashi, Hiroshi Ujike, Nakao Iwata, Toshiya Inada, Mitsuhiko Yamada, Yoshimoto Sekine, Naohisa Uchimura, Masaomi Iyo, Norio Ozaki, Masanari Itokawa and Ichiro Sora

Association between the Regulator of G-protein Signaling 9 Gene and Patients with Methamphetamine Use Disorder and Schizophrenia

Journal: Current Neuropharmacology
Volume: 9,Issue: 1
Page: 190-194
Authors: Y. Okahisa, M. Kodama, M. Takaki, T. Inada, N. Uchimura, M. Yamada, N. Iwata, M. Iyo, I. Sora, N. Ozaki and H. Ujike

The Dopaminergic System in Peripheral Blood Lymphocytes: From Physiology to Pharmacology and Potential Applications to Neuropsychiatric Disorders

Journal: Current Neuropharmacology
Volume: 9,Issue: 2
Page: 278-288
Authors: Clelia Pellicano, Francesco E. Pontieri, Alessandra Fanciulli and Francesca R. Buttarelli

Pharmacological Treatments for Cocaine Dependence: Is There Something New?

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 14
Page: 1359-1368
Authors: Laurent Karila, Michel Reynaud, Henri-Jean Aubin, Benjamin Rolland, Dewi Guardia, Olivier Cottencin and Amine Benyamina

Fibromyalgia: Mechanisms, Current Treatment and Animal Models

Journal: Current Pharmaceutical Biotechnology
Volume: 12,Issue: 10
Page: 1613-1626
Authors: Jill-Desiree Brederson, Michael F. Jarvis, Prisca Honore and Carol S. Surowy

GCH1, BH4 and Pain

Journal: Current Pharmaceutical Biotechnology
Volume: 12,Issue: 10
Page: 1728-1741
Authors: Alban Latremoliere and Michael Costigan

Classical Neurotransmitters and Neuropeptides Involved in Generalized Epilepsy: A Focus on Antiepileptic Drugs

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 32
Page: 4933-4948
Authors: F.-M. Werner and R. Covenas

Therapeutic Potential of Monoamine Transporter Substrates

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 17
Page: 1845-1859
Authors: Richard B. Rothman and Michael H. Baumann

PDZ Domain Protein-Protein Interactions: A Case Study with PICK1

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 1
Page: 3-20
Authors: Kumlesh K. Dev

Ovarian Hyperstimulation Syndrome: The Best Approaches for Preven-tion and Treatment: A Mini-Review

Journal: Current Women`s Health Reviews
Volume: 3,Issue: 1
Page: 49-54
Authors: Massimo Manno, Francesco Tomei, Alessandro Fasciani and Mauro Costa

Neurochemistry and Pharmacological Treatments: Where is the Field of Anorexia Nervosa Heading?

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 7,Issue: 1
Page: 35-43
Authors: Nicole C. Barbarich-Marsteller

Bupropion HCL and Sleep in Patients with Depression

Journal: Current Psychiatry Reviews
Volume: 3,Issue: 2
Page: 123-128
Authors: Andrew D. Krystal, Michael E. Thase, Vivian L. Tucker and Elizabeth P. Goodale

Molecule of the Month

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 13
Page: 1330-1330
Authors: Micah L. Breininger and Craig W. Lindsley

Medicinal Chemistry of A2A Adenosine Receptor Antagonists

Journal: Current Topics in Medicinal Chemistry
Volume: 3,Issue: 4
Page: 403-411
Authors: Barbara Cacciari, Giorgia Pastorin and Giampiero Spalluto

Ketanserin and Spiperone as Templates for Novel Serotonin 5-HT2A Antagonists

Journal: Current Topics in Medicinal Chemistry
Volume: 2,Issue: 6
Page: 539-558
Authors: Richard A. Glennon, Kamel Metwally, Malgorzata Dukat, Abd M. Ismaiel, Joseph De. Los Angeles, Jeffery Herndon, Milt Teitler and Nantaka Khorana

Application of Ligand SAR, Receptor Modeling and Receptor Mutagenesis to the Discovery and Development of a New class of 5-HT2A Ligands

Journal: Current Topics in Medicinal Chemistry
Volume: 2,Issue: 6
Page: 575-598
Authors: Richard B. Westkaemper and Richard A. Glennon

The Pathophysiological Role of the Serotonergic System in Tourette Syndrome

Journal: Current Psychiatry Reviews
Volume: 3,Issue: 4
Page: 271-276
Authors: Kirsten R. Muller-Vahl

The Evolution of Pharmacological Treatment for Parkinsons Disease

Journal: Recent Patents on CNS Drug Discovery
Volume: 3,Issue: 1
Page: 50-54
Authors: Quincy J. Almeida and H. Christopher Hyson

Recent Clinical Aspects of Eating Disorders

Journal: Reviews on Recent Clinical Trials
Volume: 4,Issue: 1
Page: 63-69
Authors: Anna Capasso, Claudio Petrella and Walter Milano

Autonomic Nervous System Alterations in Rett Syndrome

Journal: Current Pediatric Reviews
Volume: 5,Issue: 3
Page: 160-168
Authors: Maurizio Acampa and Francesca Guideri

Novel Therapies for Schizophrenia: Understanding the Glutamatergic Synapse and Potential Targets for Altering N-methyl-D-aspartate Neurotransmission

Journal: Recent Patents on CNS Drug Discovery
Volume: 4,Issue: 3
Page: 220-238
Authors: Christina Hui, Brian Wardwell and Guochuan E. Tsai

Half a Century of l-DOPA

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 880-893
Authors: Maria Angeles Mena, Maria Jose Casarejos, Rosa Maria Solano and Justo Garcia de Yebenes

Genetic Susceptibility to Behavioural and Psychological Symptoms in Alzheimer Disease

Journal: Current Alzheimer Research
Volume: 7,Issue: 2
Page: 158-164
Authors: B. Borroni, C. Costanzi and A. Padovani

RETRACTION OF ARTICLE

Journal: Medicinal Chemistry
Volume: 7,Issue: 1
Page: 70-70
Authors: Bentham Science Publishers

The Evolution of Histamine H3 Antagonists/Inverse Agonists

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 6
Page: 648-660
Authors: Evan P. Lebois, Carrie K. Jones and Craig W. Lindsley

Catatonia: A Narrative Review

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 11,Issue: 1
Page: 73-79
Authors: Michele Fornaro

Sigma Receptors and Cocaine Abuse

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 9
Page: 1128-1150
Authors: Sanju Narayanan, Christophe Mesangeau, Jacques H. Poupaert and Christopher R. McCurdy

Promising Medications for Cocaine Dependence Treatment

Journal: Recent Patents on CNS Drug Discovery
Volume: 6,Issue: 2
Page: 146-160
Authors: Lorenzo Somaini, Claudia Donnini, Maria A. Raggi, Mario Amore, Roberto Ciccocioppo, Maria A. Saracino, Marsida Kalluppi, Marco Malagoli, Maria L. Gerra and Gilberto Gerra

Liver Growth Factor Promotes the Survival of Grafted Neural Stem Cells in a Rat Model of Parkinson's Disease

Journal: Current Stem Cell Research & Therapy
Volume: 7,Issue: 1
Page: 15-25
Authors: Diana Reimers, Cristina Osuna, Rafael Gonzalo-Gobernado, Antonio S. Herranz, Juan Jose Diaz-Gil, Adriano Jimenez-Escrig, Maria Jose Asensio, Cristina Miranda, Macarena Rodriguez-Serrano and Eulalia Bazan

GPE and GPE Analogues as Promising Neuroprotective Agents

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12,Issue: 1
Page: 13-23
Authors: I. Cacciatore, C. Cornacchia, L. Baldassarre, E. Fornasari, A. Mollica, A. Stefanucci and F. Pinnen

Bulimia Nervosa and Alcohol Use Disorder: Evidence for Shared Etiology and Neurobiology

Journal: Current Psychiatry Reviews
Volume: 8,Issue: 1
Page: 69-81
Authors: Zeynep Yilmaz, Allan S. Kaplan and Laurie A. Zawertailo

The Putative Neuroprotective Role of Neuropeptide Y in the Central Nervous System

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 4,Issue: 4
Page: 331-347
Authors: A. P. Silva, S. Xapelli, E. Grouzmann and C. Cavadas

The Hydrogen Peroxide and its Importance in Alzheimers and Parkinsons Disease

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 4,Issue: 4
Page: 279-285
Authors: M. Jimenez Del Rio and C. Velez-Pardo

New Perspectives in the Treatment of Cushings Syndrome

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 4,Issue: 4
Page: 335-342
Authors: M. Labeur, E. Arzt, G. K. Stalla and M. Paez-Pereda

Obesity: Genetics, Behavior or a Combination of Both

Journal: Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents
Volume: 4,Issue: 2
Page: 105-111
Authors: David Meyre, Philippe Boutin and Philippe Froguel

Serotonin and Obesity

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 3,Issue: 2
Page: 89-100
Authors: A. Laviano and M. M. Meguid

A Review of Neuropeptide and Neuroendocrine Dysregulation in Anorexia and Bulimia Nervosa

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 2,Issue: 1
Page: 53-59
Authors: Ursula F. Bailer and Walter H. Kaye

Conformationally Constrained Butyrophenones. Synthesis and Evaluation as Antipsychotics

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 1,Issue: 1
Page: 43-62
Authors: Enrique Ravina and Christian F. Masaguer

Modafinil: A Useful Medication for Cocaine Addiction? Review of the Evidence from Neuropharmacological, Experimental and Clinical Studies

Journal: Current Drug Abuse Reviews
Volume: 1,Issue: 2
Page: 213-221
Authors: Jose Martinez-Raga, Carlos Knecht and Sonsoles Cepeda

Therapeutic Strategies in Parkinsons Disease

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 2,Issue: 2
Page: 135-147
Authors: Muchukunte M.S. Bharath

Hypothesis-Driven Medication Discovery for the Treatment of Psychostimulant Addiction

Journal: Current Drug Abuse Reviews
Volume: 1,Issue: 3
Page: 303-327
Authors: Zheng-Xiong Xi and Eliot L. Gardner

Neuronal Nicotinic Receptors as Brain Targets for Pharmacotherapy of Drug Addiction

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 5
Page: 422-441
Authors: Shafiqur Rahman, Gretchen Y. Lopez-Hernandez, William A. Corrigall and Roger L. Papke

Synthesis of [18F]Fallypride in a Micro-Reactor: Rapid Optimization and Multiple-Production in Small Doses for Micro-PET Studies

Journal: Current Radiopharmaceuticals
Volume: 2,Issue: 1
Page: 49-55
Authors: Shuiyu Lu, Anthony M. Giamis and Victor W. Pike

Mechanisms of Sleep-Wake Cycle Modulation

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8,Issue: 4
Page: 245-253
Authors: Eric Murillo-Rodriguez, Oscar Arias-Carrion, Katya Sanguino-Rodriguez, Mauricio Gonzalez-Arias and Reyes Haro

Neuropharmacology of the Interoceptive Stimulus Properties of Nicotine

Journal: Current Drug Abuse Reviews
Volume: 2,Issue: 3
Page: 243-255
Authors: Thomas E. Wooters, Rick A. Bevins and Michael T. Bardo

Treating Schizophrenia: Novel Targets for the Cholinergic System

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9,Issue: 2
Page: 241-256
Authors: T.T. Money, E. Scarr, M. Udawela, A.S. Gibbons, W.J. Jeon, M.S. Seo and B. Dean

An Essential Role for Adenosine Signaling in Alcohol Abuse

Journal: Current Drug Abuse Reviews
Volume: 3,Issue: 3
Page: 163-174
Authors: Christina L. Ruby, Chelsea A. Adams, Emily J. Knight, Hyung Wook Nam and Doo-Sup Choi

Therapeutic Targets for the Management of Peripheral Nerve Injury- Induced Neuropathic Pain

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 5
Page: 589-609
Authors: Amteshwar Singh Jaggi and Nirmal Singh

Targeting Nicotinic Receptors for Parkinson's Disease Therapy

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 6
Page: 651-658
Authors: Maryka Quik, Tanuja Bordia, Luping Huang and Xiomara Perez

The Face of Uncertainty Eats

Journal: Current Drug Abuse Reviews
Volume: 4,Issue: 3
Page: 174-181
Authors: Rebecca L.W. Corwin

Nitric Oxide Modulation of the Basal Ganglia Circuitry: Therapeutic Implication for Parkinson's Disease and Other Motor Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 7
Page: 777-791
Authors: Massimo Pierucci, Salvatore Galati, Mario Valentino, Vincenzo Di Matteo, Arcangelo Benigno, Alessandro Pitruzzella, Richard Muscat and Giuseppe Di Giovanni

Inflammation and Age-Related Iron Accumulation in F344 Rats

Journal: Current Aging Science
Volume: 1,Issue: 2
Page: 112-121
Authors: Randy L. Hunter, Mei Liu, Dong Young Choi, Wayne A. Cass and Guoying Bing

Pathological Gambling: Neuropsychopharmacology and Treatment

Journal: Current Psychopharmacology
Volume: 1,Issue: 1
Page: 67-85
Authors: Scott A. Bullock and Marc N. Potenza

α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson’s Disease

Journal: Current Drug Targets
Volume: 13,Issue: 5
Page: 623-630
Authors: Jun Kawamata, Syuuichirou Suzuki and Shun Shimohama

Basic Sleep Mechanisms: An Integrative Review

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 12,Issue: 1
Page: 38-54
Authors: Eric Murillo-Rodriguez, Oscar Arias-Carrion, Abraham Zavala-Garcia, Andrea Sarro-Ramirez, Salvador Huitron-Resendiz and Gloria Arankowsky-Sandoval

COMT as a Drug Target for Cognitive Functions and Dysfunctions

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 209-221
Authors: Diego Scheggia, Sara Sannino, Maria Luisa Scattoni and Francesco Papaleo

Catechol-O-Methyltransferase and Alzheimer's Disease: A Review of Biological and Genetic Findings

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 299-305
Authors: Alessandro Serretti and Paolo Olgiati

Immunological Treatment Options for Schizophrenia

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 8
Page: 1606-1613
Authors: Norbert Muller, Aye-Mu Myint and Markus J. Schwarz

Mitochondria as an Easy Target to Oxidative Stress Events in Parkinson's Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 430-438
Authors: Marcella Reale, Mirko Pesce, Medha Priyadarshini, Mohammad A Kamal and Antonia Patruno

Motor and Non-Motor Features of Parkinson’s Disease – A Review of Clinical and Experimental Studies

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 439-449
Authors: Marcelo M.S. Lima, Emerson F. Martins, Ana Marcia Delattre, Mariana B. Proenca, Marco A. Mori, Bruno Carabelli and Anete C. Ferraz

Vasoactive Compounds in the Neonatal Period

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 27
Page: 4633-4639
Authors: P. Toth-Heyn and L. Cataldi

Pharmacological Innovations for Posttraumatic Stress Disorder and Medication- Enhanced Psychotherapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 35
Page: 5645-5658
Authors: Boadie W. Dunlop, Erika Mansson and Maryrose Gerardi

Mechanism of Action of Methamphetamine within the Catecholamine and Serotonin Areas of the Central Nervous System

Journal: Current Drug Abuse Reviews
Volume: 5,Issue: 3
Page: 227-242
Authors: Veronica M. Chiu and James O. Schenk

Effects of Antipsychotics on the BDNF in Schizophrenia

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 345-350
Authors: T. L. Huang

Transcranial Brain Stimulation in Schizophrenia: Targeting Cortical Excitability, Connectivity and Plasticity

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 405-413
Authors: A. Hasan, P. Falkai and T. Wobrock

Systematic Review of the Influence of Antipsychotics on the Blood Oxygenation Level-Dependent Signal of Functional Magnetic Resonance Imaging

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 448-461
Authors: C. H. Roder, S. Dieleman, F. M. van der Veen and D. Linden

Nuclear Factor Erythroid 2 - Related Factor 2 Signaling in Parkinson Disease: A Promising Multi Therapeutic Target Against Oxidative Stress, Neuroinflammation and Cell Death

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 8
Page: 1015-1029
Authors: Hemant Kumar, Sushruta Koppula, In-Su Kim, Sandeep Vasant More, Byung-Wook Kim and Dong-Kug Choi


Serotonin2C Receptors and the Motor Control of Oral Activity

Journal: Current Neuropharmacology
Volume: 11,Issue: 2
Page: 160-170
Authors: Melanie Lagiere, Sylvia Navailles, Marion Bosc, Martin Guthrie and Philippe De Deurwaerdere

Aromatherapy and the Central Nerve System (CNS): Therapeutic Mechanism and its Associated Genes

Journal: Current Drug Targets
Volume: 14,Issue: 8
Page: 872-879
Authors: Xiao Nan Lv, Zhu Jun Liu, Huan Jing Zhang and Chi Meng Tzeng

Ginkgo Biloba Extract in an Animal Model of Parkinson’s Disease: A Systematic Review

Journal: Current Neuropharmacology
Volume: 11,Issue: 4
Page: 430-435
Authors: K. Tanaka, R. F. S.-Galduroz, L. T. B. Gobbi and J. C. F. Galduroz

Classical Neurotransmitters and Neuropeptides Involved in Schizophrenia: How to Choose the Appropriate Antipsychotic Drug?

Journal: Current Drug Therapy
Volume: 8,Issue: 2
Page: 132-143
Authors: Felix-Martin Werner and Rafael Covenas

Multiple Intranigral Unilateral LPS Infusion Protocol Generates a Persistent Cognitive Impairment without Cumulative Dopaminergic Impairment

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 7
Page: 1002-1010
Authors: Ana Marcia Delattre, Bruno Carabelli, Marco Aurélio Mori, Claudia Pudell, Danielle R.B.L. da Silva, Isabela Menezes, Paula R.G. Kempe, Pedro Vinícius Staziaki, Patrícia A. Dombrowski, Claudio da Cunha, Marcelo M.S. Lima and Anete C. Ferraz

The Neuroprotective Effects of Purslane (Portulaca oleracea) on Rotenone- Induced Biochemical Changes and Apoptosis in Brain of Rat

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 6
Page: 830-841
Authors: Ahmed E. Abdel Moneim

Antipsychotics Management in Addictive Disorders

Journal: Current Psychopharmacology
Volume: 2,Issue: 3
Page: 212-217
Authors: Pierre Alexis Geoffroy, Benjamin Rolland, Vincent Laprevote and Olivier Cottencin

Vitamin D: Preventive and Therapeutic Potential in Parkinson’s disease

Journal: Current Drug Metabolism
Volume: 14,Issue: 9
Page: 989-993
Authors: Yan Liu, Yan-Wu Li, Ya-Lan Tang, Xin Liu, Jun-Hao Jiang, Qing-Gen Li and Jian-Yong Yuan

Haloperidol Cytotoxicity and Its Relation to Oxidative Stress

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13,Issue: 14
Page: 1993-1998
Authors: Martina Raudenska, Jaromir Gumulec, Petr Babula, Tibor Stracina, Marketa Sztalmachova, Hana Polanska, Vojtech Adam, Rene Kizek, Marie Novakova and Michal Masarik

Current Therapeutic Advances in Patients and Experimental Models of Huntington's Disease

Journal: Current Drug Targets
Volume: 15,Issue: 3
Page: 313-334
Authors: Ana C. Brett, Tatiana R. Rosenstock and A. Cristina Rego

Attentional Set-Shifting in Rodents: A Review of Behavioural Methods and Pharmacological Results

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 31
Page: 5046-5059
Authors: David S. Tait, E. Alexander Chase and Verity J. Brown

Treatment of Antipsychotic-Induced Hyperprolactinemia: An Update on the Role of the Dopaminergic Receptors D2 Partial Agonist Aripiprazole

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 8,Issue: 1
Page: 30-37
Authors: Domenico De Berardis, Michele Fornaro, Nicola Serroni, Stefano Marini, Monica Piersanti, Marilde Cavuto, Alessandro Valchera, Monica Mazza, Gabriella Girinelli, Felice Iasevoli, Giampaolo Perna, Giovanni Martinotti and Massimo Di Giannantonio

Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 13,Issue: 3
Page: 166-194
Authors: Nidhi Jatana, N. Apoorva, Sonika Malik, Aditya Sharma and Narayanan Latha

The Multimodal Treatment of Acromegaly: Current Status and Future Perspectives

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 14,Issue: 3
Page: 169-181
Authors: Etual Espinosa, Claudia Ramirez and Moises Mercado

Neuroprotective Effects of Citrus reticulata in Scopolamine-Induced Dementia Oxidative Stress in Rats

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 4
Page: 684-690
Authors: Manal F. El-Khadragy, Ebtesam M. Al-Olayan and Ahmed E. Abdel Moneim

A Novel Prion Protein-Tyrosine Hydroxylase Interaction

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 5
Page: 896-908
Authors: Mattia Vicario, Adriana Zagari, Vincenzo Granata, Francesca Munari, Stefano Mammi, Luigi Bubacco, Stephen D. Skaper and Alessandro Negro

The Paths to Neurodegeneration in Genetic Parkinson's Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 9
Page: 1485-1512
Authors: Omar M.E. Abdel-Salam

Optimisation of [11C]Raclopride Production Using a Synthra GPextent System

Journal: Current Radiopharmaceuticals
Volume: 7,Issue: 2
Page: 100-106
Authors: Gary Perkins, Rajeev Sheth, Ivan Greguric and Giancarlo Pascali

Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective

Journal: Current Neuropharmacology
Volume: 13,Issue: 3
Page: 395-406
Authors: Lurdes Tse, Alasdair M. Barr, Vanessa Scarapicchia and Fidel Vila-Rodriguez

Intrahypothalamic Administration of Modafinil Increases Expression of MAP-Kinase in Hypothalamus and Pons in Rats

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 4
Page: 463-467
Authors: Alwin Poot-Ake, Stephanie Mijangos-Moreno, Danielle Manjarrez-Martin, Ramses Jimenez-Moreno, Pedro R. Aquino-Hernandez, Elda Pacheco-Pantoja, Oscar Arias-Carrion, Andrea Sarro-Ramirez, Gloria Arankowsky-Sandoval and Eric Murillo-Rodriguez

New Molecules as Drug Candidates for the Treatment of Upper and Lower GI Tract Ulcers

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 21
Page: 2993-3001
Authors: Sandor Szabo and Ganna Tolstanova

Effect of Acute Administration of 8-(Trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine Hydrochloride (TC-2153) on Biogenic Amines Metabolism in Mouse Brain

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 10
Page: 833-836
Authors: Elizabeth A. Kulikova, Ekaterina Y. Bazhenova, Nina K. Popova, Tatyana M. Khomenko, Konstantin P. Volcho, Nariman F. Salakhutdinov and Alexander V. Kulikov

Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 6
Page: 692-699
Authors: Ryan Bachtell, Mark R. Hutchinson, Xiaohui Wang, Kenner C. Rice, Steven F. Maier and Linda R. Watkins

Nitric Oxide (NO) System in Major Depression: Studies on NO Synthase Inhibitors as Antidepressant Agents

Journal: Current Enzyme Inhibition
Volume: 12,Issue: 1
Page: 40-48
Authors: Ashish Dhir and Shrinivas K. Kulkarni

Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson’s Disease

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 10
Page: 1305-1311
Authors: Juan Camilo Jurado-Coronel, Marco Avila-Rodriguez, Francisco Capani, Janneth Gonzalez, Valentina Echeverria Moran and George E. Barreto

Targeting Dopaminergic System for Treating Nicotine Dependence

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 137-142
Authors: Sawsan Abuhamdah, Ashraf Khalil and Youssef Sari

The Nuclear Molecular Imaging of Protein Brain Receptors in Chronic Pain

Journal: Current Protein & Peptide Science
Volume: 17,Issue: 6
Page: 559-569
Authors: Chen Su, Rong Hu, Yonghong Gu, Rui Han, Xuebin Yan, Qin Liao and Dong Huang

Design and Synthesis of Dopaminergic Agonists

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 25
Page: 2790-2825
Authors: Maria Soledad Matute, Rosa Matute and Pedro Merino

Probiotics as an Adjuvant Therapy in Major Depressive Disorder

Journal: Current Neuropharmacology
Volume: 14,Issue: 8
Page: 952-958
Authors: Josipa Vlainić Vlainić, Jelena Šuran, Toni Vlainić and Antonella Letizia Vukorep

Antibacterial Properties of Multi-walled Carbon Nanotubes Decorated with Silver Nanoparticles

Journal: Current Nanoscience
Volume: 12,Issue: 4
Page: 411-415
Authors: Yingzhu Liu, Yuetong Hu, Rongsheng Chen, Weiting Zhan, Hongwei Ni, Peiming Zhang and Feng Liang

New Insights Emerging from Recent Investigations on Human Group II Pyridoxal 5’-Phosphate Decarboxylases

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 3
Page: 226-244
Authors: Alessandro Paiardini, Giorgio Giardina, Giada Rossignoli, Carla Borri Voltattorni and Mariarita Bertoldi

Voltammetric Investigation and Determination of Piribedil in Pharmaceutical Dosage Forms Using Carbon-Based Electrodes

Journal: Current Pharmaceutical Analysis
Volume: 13,Issue: 1
Page: 91-98
Authors: Burcin Bozal-Palabiyik and Bengi Uslu

Smoking and Cognition

Journal: Current Drug Abuse Reviews
Volume: 9,Issue: 2
Page: 76-79
Authors: Marcela Waisman Campos, Debora Serebrisky and Joao Mauricio Castaldelli-Maia

Association of DRD2 TaqIA and DβH -1021C>T Gene Polymorphisms with Smoking Initiation and their Interaction with Serotonergic System Gene Polymorphisms

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 11,Issue: 2
Page: 110-117
Authors: Georgia Ragia, Maria Iordanidou, Efstathia Giannakopoulou, Anna Tavridou and Vangelis G. Manolopoulos

Atypicality of Atypical Antipsychotics Revisited

Journal: Current Psychiatry Reviews
Volume: 9,Issue: 4
Page: 316-324
Authors: Andrew Farah

Translational Pharmacology of a Putative Measure of Motor Impulsivity in Larval Zebrafish

Journal: Current Psychopharmacology
Volume: 5,Issue: 2
Page: 73-84
Authors: Matthew O. Parker and Caroline H. Brennan

Pharmacogenetic Aspects of Neuroleptic Malignant Syndrome

Journal: Current Pharmacogenomics
Volume: 4,Issue: 2
Page: 113-119
Authors: Chiaki Kawanishi, Ikuko Kishida, Taku Furuno, Daiji Kato and Leif Bertilsson

Psychotic (Delusional) Major Depression in the Elderly: A Review

Journal: Current Psychiatry Reviews
Volume: 2,Issue: 2
Page: 235-244
Authors: Rossetos Gournellis and Lefteris Lykouras

Progress Towards Validating the NMDA Receptor Hypofunction Hypothesis of Schizophrenia

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 8
Page: 771-785
Authors: Craig W. Lindsley, William D. Shipe, Scott E. Wolkenberg, Cory R. Theberge, David L. Williams Jr., Cyrille Sur and Gene G. Kinney

PET Imaging of Norepinephrine Transporters

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 30
Page: 3831-3845
Authors:

The Regulation of Liver Cytochrome P450 by the Brain Dopaminergic System

Journal: Current Drug Metabolism
Volume: 8,Issue: 6
Page: 631-638
Authors: Jacek Wojcikowski, Krystyna Golembiowska and Wladyslawa Anna Daniel

The Pharmacokinetics and Pharmacodynamics of Levodopa in the Treatment of Parkinsons Disease

Journal: Current Clinical Pharmacology
Volume: 2,Issue: 3
Page: 234-243
Authors: Soo-Peang Khor and Ann Hsu

Sensory-Motor Integration in the Medial Medulla

Journal: Current Neuropharmacology
Volume: 3,Issue: 2
Page: 115-143
Authors: Yuan-Yang Lai and Jerome M. Siegel

Pharmacology of Motor and Somatosensory Skills in Humans

Journal: Current Neuropharmacology
Volume: 3,Issue: 2
Page: 145-156
Authors: Burkhard Pleger, Martin Tegenthoff, Hubert Dinse, Patrick Ragert and Peter Schwenkreis

Iptakalim Hydrochloride and Neuronal Protection

Journal: Current Neuropharmacology
Volume: 3,Issue: 3
Page: 249-256
Authors: Jie Wu, Makoto Wakui, Hai Wang and Gang Hu

Computer-Aided Drug Design for Typical and Atypical Antipsychotic Drugs: A Review of Application of QSAR and Combinatorial Chemistry Methods - Tools for New Antipsychotics Design

Journal: Current Computer Aided-Drug Design
Volume: 1,Issue: 4
Page: 347-364
Authors: S. Avram, A.- L. Milac and M. L. Flonta

Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function

Journal: Current Neuropharmacology
Volume: 3,Issue: 1
Page: 9-34
Authors: Laura E. Chavez-Noriega, Michael J. Marino, Herve Schaffhauser, Una C. Campbell and P. Jeffrey Conn

Hypericin - The Facts About a Controversial Agent

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 2
Page: 233-253
Authors: A. Kubin, F. Wierrani, U. Burner, G. Alth and W. Grunberger

Synthesis and Pharmacological Activities of Amine-Boranes

Journal: Current Medicinal Chemistry
Volume: 12,Issue: 17
Page: 1995-2010
Authors: Bruce S. Burnham

New Antipsychotics and Schizophrenia: A Review on Efficacy and Side Effects

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 3
Page: 343-358
Authors: Alessandro Serretti, Diana De Ronchi, Cristina Lorenzi and Domenico Berardi

Animal Models for Obsessive-Compulsive Disorder

Journal: Current Neuropharmacology
Volume: 2,Issue: 2
Page: 169-181
Authors: J. Man, A. L. Hudson, D. Ashton and D. J. Nutt

Recent Approaches to Novel Anti-Alzheimer Therapy

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 25
Page: 3167-3175
Authors: Carreiras M. C. and Marco J. L.

Cannabinoid Receptor Activation and the Endocannabinoid System in the Gastrointestinal Tract

Journal: Current Neuropharmacology
Volume: 2,Issue: 1
Page: 91-102
Authors: A. A. Coutts

The Pharmacology of Human Appetite Expression

Journal: Current Drug Targets
Volume: 5,Issue: 3
Page: 221-240
Authors: Jason C.G. Halford, Gillian D. Cooper and Terence M. Dovey

Glutamate-regulated Behavior, Transmitter Release, Gene Expression and Addictive Plasticity in the Striatum: Roles of Metabotropic Glutamate Receptors

Journal: Current Neuropharmacology
Volume: 1,Issue: 1
Page: 1-20
Authors: John Q. Wang, Limin Mao, Nikhil K. Parelkar, Qingsong Tang, Zhenguo Liu, Shazia Sarwar and Eun Sang Choe

An Update on the Extraneuronal Monoamine Transporter (EMT): Characteristics, Distribution and Regulation

Journal: Current Drug Metabolism
Volume: 4,Issue: 4
Page: 313-318
Authors: F. Martel and I. Azevedo

Disorders of Tetrahydrobiopterin Metabolism and their Treatment

Journal: Current Drug Metabolism
Volume: 3,Issue: 2
Page: 123-131
Authors: H. Shintaku

Schizophrenia: Genesis, Receptorology and Current Therapeutics

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 5
Page: 521-548
Authors: B. Capuano, I. T. Crosby and E. J. Lloyd

Sulfotransferase Inhibition: Potential Impact of Diet and Environmental Chemicals on Steroid Metabolism and Drug Detoxification

Journal: Current Drug Metabolism
Volume: 9,Issue: 4
Page: 269-275
Authors: R. M. Harris and R. H. Waring

Role of the Central Cholinergic System in the Therapeutics of Schizophrenia

Journal: Current Neuropharmacology
Volume: 6,Issue: 3
Page: 286-292
Authors: Alvin V. Terry and Jr.

On the Pathogenesis and Neuroprotective Treatment of Parkinson Disease: What have we Learned from the Genetic Forms of this Disease?

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 23
Page: 2305-2320
Authors: M. A. Mena, J. A. Rodriguez-Navarro, R. Ros and J. G. de Yebenes

Molecular Genetics of Alcohol Dependence and Related Endophenotypes

Journal: Current Genomics
Volume: 9,Issue: 7
Page: 444-451
Authors: Yann L. Strat, Nicolas Ramoz, Gunter Schumann and Philip Gorwood

Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 14
Page: 1647-1674
Authors: Karl Ebner, Simone B. Sartori and Nicolas Singewald

Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 22
Page: 2550-2559
Authors: O. D. Howes, A. Egerton, V. Allan, P. McGuire, P. Stokes and S. Kapur

Research and Development of Nuclear Molecular Imaging in Taiwan

Journal: Current Medical Imaging Reviews
Volume: 5,Issue: 4
Page: 242-254
Authors: Lie-Hang Shen, Yu-Chin Tseng, Chih-Hsien Chang and Chia-Chieh Chen

Therapeutic Utility of NK3 Receptor Antagonists for the Treatment of Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 3
Page: 344-357
Authors: Lee A. Dawson and Paul W. Smith

Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 5
Page: 488-501
Authors: Richard B. Mailman and Vishakantha Murthy

Pharmacogenetics of Alcohol and Alcohol Dependence Treatment

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 19
Page: 2141-2148
Authors: Henry R. Kranzler and Howard J. Edenberg

Neurotoxicity of Ecstasy (MDMA): An Overview

Journal: Current Pharmaceutical Biotechnology
Volume: 11,Issue: 5
Page: 460-469
Authors: Sumit Sarkar and Larry Schmued

Stimulant Drug Effects on Attention Deficit/Hyperactivity Disorder: A Review of the Effects of Age and Sex of Patients

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 22
Page: 2424-2433
Authors: Christine Cornforth, Edmund Sonuga-Barke and David Coghill

Involvement of Cytosolic Phospholipase A2, Calcium Independent Phospholipase A2 and Plasmalogen Selective Phospholipase A2 in Neurodegenerative and Neuropsychiatric Conditions

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 25
Page: 2746-2763
Authors: W.-Y. Ong, T. Farooqui and A.A. Farooqui

The Role of the Nervous System in the Regulation of Liver Cytochrome P450

Journal: Current Drug Metabolism
Volume: 12,Issue: 2
Page: 124-138
Authors: Jacek Wojcikowski and Wladyslawa Anna Daniel

Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 16
Page: 1612-1632
Authors: Predrag Sikiric, Sven Seiwerth, Rudolf Rucman, Branko Turkovic, Dinko Stancic Rokotov, Luka Brcic, Marko Sever, Robert Klicek, Bozo Radic, Domagoj Drmic, Spomenko Ilic, Danijela Kolenc, Hrvoje Vrcic and Bozidar Sebecic

A Fluorescence Polarization Based Screening Assay for Identification of Small Molecule Inhibitors of the PICK1 PDZ Domain

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 14,Issue: 7
Page: 590-600
Authors: Thor S. Thorsen, Kenneth L. Madsen, Tino Dyhring, Anders Bach, Dan Peters, Kristian Stromgaard and Ulrik Gether

Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors:Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure

Journal: Current Neuropharmacology
Volume: 9,Issue: 3
Page: 478-511
Authors: Sarah K. Williams, Jean M. Lauder and Josephine M. Johns

Depot Based Drug Delivery System for the Management of Depression

Journal: Current Drug Delivery
Volume: 8,Issue: 5
Page: 483-493
Authors: Urmila Pilaniya, Kapil Khatri and U. K. Patil

Quick-Release Bromocriptine for Treatment of Type 2 Diabetes

Journal: Current Drug Delivery
Volume: 8,Issue: 5
Page: 511-516
Authors: Nasser Mikhail

Emerging Targets for the Pharmacological Treatment of Depression: Focus on Melatonergic System

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 3
Page: 428-437
Authors: Mario Catena-Dell'Osso, Donatella Marazziti, Francesco Rotella and Cesario Bellantuono

“Liking” and “Wanting” Linked to Reward Deficiency Syndrome (RDS): Hypothesizing Differential Responsivity in Brain Reward Circuitry

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 113-118
Authors: Kenneth Blum, Eliot Gardner, Marlene Oscar-Berman and Mark Gold

A Current Review of Cypermethrin-Induced Neurotoxicity and Nigrostriatal Dopaminergic Neurodegeneration

Journal: Current Neuropharmacology
Volume: 10,Issue: 1
Page: 64-71
Authors: Anand Kumar Singh, Manindra Nath Tiwari, Om Prakash and Mahendra Pratap Singh

What is the Evidence for the use of Adrenaline in the Treatment of Neonatal Hypotension?

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 10,Issue: 1
Page: 50-98
Authors: Liam Mahoney, David Crook, Kerstin N. Walter, Ella Sherman and Heike Rabe

Serotonin 5-HT2A and 5-HT2C Receptors as Potential Targets for Modulation of Psychostimulant Use and Dependence

Journal: Current Topics in Medicinal Chemistry
Volume: 6,Issue: 18
Page: 1971-1985
Authors: Marcy J. Bubar and Kathryn A. Cunningham

The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 1
Page: 3-19
Authors: M. D. Berry

Secretoneurin: A New Player in Angiogenesis and Chemotaxis Linking Nerves, Blood Vessels and the Immune System

Journal: Current Protein & Peptide Science
Volume: 6,Issue: 4
Page: 373-385
Authors: Reiner Fischer-Colbrie, Rudolf Kirchmair, Christian M. Kahler, Christian J. Wiedermann and Alois Saria

mGlu5 Receptors: Neuroanatomy, Pharmacology, and Role in Drug Addiction

Journal: Current Psychiatry Reviews
Volume: 1,Issue: 2
Page: 197-214
Authors: M. Foster Olive

The Physiology of Learning and Memory: Role of Peptides and Stress

Journal: Current Protein & Peptide Science
Volume: 5,Issue: 6
Page: 457-473
Authors: M. A. Gulpinar and B. C. Yegen

Development of Radioligands for Imaging of Brain Norepinephrine Transporters In Vivo with Positron Emission Tomography

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 18
Page: 1806-1816
Authors: Magnus Schou, Victor W. Pike and Christer Halldin

Fenoldopam in Cardiovascular Surgery: A Review

Journal: Vascular Disease Prevention
Volume: 5,Issue: 4
Page: 223-226
Authors: Giovanni Landoni, Francesco A. Garozzo, Anna Mizzi and Alberto Zangrillo

Histamine H3-Receptor Inverse Agonists as Novel Antipsychotics

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 9,Issue: 2
Page: 132-136
Authors: Chihiro Ito

New Molecular Avenues in Parkinson ’ s Disease Therapy

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 10
Page: 913-948
Authors: Mario Di Napoli

New Insight into the Therapeutic Role of 5-HT1A Receptors in Central Nervous System Disorders

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 10,Issue: 2
Page: 148-157
Authors: Yukihiro Ohno

Recent Clinical Aspects of Hyperprolactinemia Induced by Antipsychotics

Journal: Reviews on Recent Clinical Trials
Volume: 6,Issue: 1
Page: 52-64
Authors: Walter Milano, Cosimo Walter D'Acunto, Michele De Rosa, Michela Festa, Luca Milano, Claudio Petrella and Anna Capasso

The Role of Extracellular Adenosine in Chemical Neurotransmission in the Hippocampus and Basal Ganglia: Pharmacological and Clinical Aspects

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 8
Page: 1034-1046
Authors: Beata Sperlagh and E. Sylvester Vizi

The Nociceptin/Orphanin FQ Receptor (NOP) as a Target for Drug Abuse Medications

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 9
Page: 1151-1156
Authors: Nurulain T. Zaveri

Metoclopramide as an Analgesic in Severe Migraine Attacks: An Open, Single-blind, Parallel Control Study

Journal: Recent Patents on CNS Drug Discovery
Volume: 6,Issue: 2
Page: 141-145
Authors: Gabriel Salazar, Marta Fragoso, Luis Vergez, Piera Sergio and Denisse Cuello

L-DOPA and Serotonergic Neurons: Functional Implication and Therapeutic Perspectives in Parkinson's Disease

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 11,Issue: 4
Page: 305-320
Authors: Sylvia Navailles, Manolo Carta, Martin Guthrie and Philippe De Deurwaerdere

Metabotropic Glutamate Receptors in the Control of Mood Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6,Issue: 2
Page: 87-100
Authors: Jeffrey M. Witkin, Gerard J. Marek, Bryan G. Johnson and Darryle D. Schoepp

GH-Inhibitory Activity of Novel Somatostatin Agonists: Potential Applications in Acromegaly

Journal: Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents
Volume: 5,Issue: 3
Page: 277-291
Authors: P. Dasgupta

The CNS Melanocortin System: A Biological Weapon Against the Threat of Obesity

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 3,Issue: 3
Page: 201-215
Authors: M. M. Hagan, P. C. Chandler and P. K. Wauford

Central Nervous System Agents Used as Trypanosoma cruzi Infection Chemotherapy: Phenothiazines and Related Compounds

Journal: Current Medicinal Chemistry -Anti-Infective Agents
Volume: 2,Issue: 4
Page: 323-333
Authors: P. Paglini-Oliva and H. W. Rivarola

Emerging Signalling and Protein Interactions Mediated Via Metabotropic Glutamate Receptors

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 2,Issue: 2
Page: 109-122
Authors: Randal X. Moldrich and Philip M. Beart

3,4-Dihydroxyphenylacetaldehyde: A Potential Target for Neuroprotective Therapy in Parkinsons Disease

Journal: Current Drug Target -CNS & Neurological Disorders
Volume: 2,Issue: 2
Page: 143-148
Authors: W. J. Burke

The Genetic Components of Alcohol and Nicotine Co-Addiction: From Genes to Behavior

Journal: Current Drug Abuse Reviews
Volume: 1,Issue: 2
Page: 124-134
Authors: Isabel R. Schlaepfer, Nicole R. Hoft and Marissa A. Ehringer

Calpain as a Potential Therapeutic Target in Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 3
Page: 305-312
Authors: Supriti Samantaray, Swapan K. Ray and Naren L. Banik

Opioid Antagonists for Pharmacological Treatment of Alcohol Dependence – A Critical Review

Journal: Current Drug Abuse Reviews
Volume: 1,Issue: 3
Page: 280-291
Authors: Michael Soyka and Susanne Rosner

The Role of 5-HT3 Receptors in Drug Abuse and as a Target for Pharmacotherapy

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 5
Page: 454-467
Authors: E. A. Engleman, Z. A. Rodd, R. L. Bell and J. M. Murphy

The proNGF-p75NTR-Sortilin Signalling Complex as New Target for the Therapeutic Treatment of Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7,Issue: 6
Page: 512-523
Authors: L. W. Chen, K. K.L. Yung, Y. S. Chan, D. K.Y. Shum and J. P. Bolam

The Use of Iontophoresis in the Administration of Nicotine and New Non-Nicotine Drugs through the Skin for Smoking Cessation

Journal: Current Drug Discovery Technologies
Volume: 6,Issue: 3
Page: 171-185
Authors: Jose Juan Escobar-Chavez, Virginia Merino, Miriam Lopez-Cervantes, Isabel Marlen Rodriguez-Cruz, David Quintanar-Guerrero and Adriana Ganem-Quintanar

Signal Transduction via Cannabinoid Receptors

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 8,Issue: 6
Page: 422-431
Authors: George D. Dalton, Caroline E. Bass, Cynthia G. Van Horn and Allyn C. Howlett

Regulation of G-Protein-Coupled Receptor Signalling by the Scaffolding Proteins Spinophilin/Neurabin 2 and Neurabin 1

Journal: Current Chemical Biology
Volume: 5,Issue: 2
Page: 130-141
Authors: Denis Sarrouilhe and Thierry Metaye

Poly-Si Nanowire Device Technology

Journal: Nanoscience & Nanotechnology-Asia
Volume: 1,Issue: 2
Page: 109-122
Authors: Horng-Chih Lin

Pharmacogenetics of Antipsychotic Drugs in Schizophrenia Treatment

Journal: Current Psychopharmacology
Volume: 1,Issue: 1
Page: 47-60
Authors: Piotr Tybura, Beata Trzesniowska-Drukala and Jerzy Samochowiec

Isolation and Characterization of Novel Tyrosinase from Laceyella sacchari

Journal: Protein & Peptide Letters
Volume: 19,Issue: 5
Page: 538-543
Authors: Aleksandar Dolashki, Wolfgang Voelter, Adriana Gushterova, Jozef Van Beeumen, Bart Devreese and Bozhidar Tchorbanov

COMT Implication in Cognitive and Psychiatric Symptoms in Chromosome 22q11 Microdeletion Syndrome: A Selective Review

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 3
Page: 273-281
Authors: Marco Armando, Francesco Papaleo and Stefano Vicari

Sympathetic Signaling in Angiogenesis: Implications for Cancer Progression

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 2
Page: 83-89
Authors: Jason Tilan, Magdalena Czarnecka and Joanna Kitlinska

Serotonin Receptors as Targets for Drugs Useful to Treat Psychosis and Cognitive Impairment in Schizophrenia

Journal: Current Pharmaceutical Biotechnology
Volume: 13,Issue: 8
Page: 1572-1586
Authors: H. Y. Meltzer, B. W. Massey and M. Horiguchi

Paradoxical Sleep Deprivation Modulates Tyrosine Hydroxylase Expression in the Nigrostriatal Pathway and Attenuates Motor Deficits Induced by Dopaminergic Depletion

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 359-368
Authors: Marcelo M.S. Lima, Monica L. Andersen, Angela B. Reksidler, Anete C. Ferraz, Maria A.B.F. Vital and Sergio Tufik

Targeting Parkinson’s - Tyrosine Hydroxylase and Oxidative Stress as Points of Interventions

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 369-380
Authors: Mohd Shahnawaz Khan, Shams Tabrez, Medha Priyadarshini, Shubha Priyamvada and Mohd M. Khan

RNAi of cat-2, a Putative Tyrosine Hydroxylase, Increases Alpha Synuclein Aggregation and Associated Effects in Transgenic C. elegans

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 387-394
Authors: Supinder Kaur, Shreesh Raj Sammi, Pooja Jadiya and Aamir Nazir

A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 395-409
Authors: Shams Tabrez, Nasimudeen R. Jabir, Shazi Shakil, Nigel H. Greig, Qamre Alam, Adel M. Abuzenadah, Ghazi A. Damanhouri and Mohammad A. Kamal

Molecular Docking Study of Catecholamines and [4-(Propan-2-yl) Phenyl]Carbamic acid with Tyrosine Hydroxylase

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 4
Page: 463-468
Authors: Zahida Parveen, Muhammad Sulaman Nawaz, Shazi Shakil, Nigel H. Greig and Mohammad A. Kamal

Impulse Control Disorders in Parkinson’s Disease: A Review

Journal: Current Psychiatry Reviews
Volume: 8,Issue: 3
Page: 235-246
Authors: Kit Wu, Marios Politis and Paola Piccini

Co-Morbidity and Self Medication in Schizophrenia: Involvement of Endogenous Morphine Signaling Mechanisms

Journal: Current Drug Targets
Volume: 13,Issue: 11
Page: 1454-1457
Authors: Richard M. Kream, Hana Kuzelova, Milena Kralickova, Radek Ptacek and George B. Stefano

Recent Progress in Gene Therapy for Parkinson’s Disease

Journal: Current Molecular Medicine
Volume: 12,Issue: 10
Page: 1311-1318
Authors: Y. Nakata, T. Yasuda and H. Mochizuki

Is Nicotine Protective Against Parkinson´s Disease? An Experimental Analysis

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 7
Page: 897-906
Authors: Jose-Ruben Garcia-Montes, Alejandra Boronat-Garcia, Ana-Maria Lopez-Colome, Jose Bargas, Magdalena Guerra-Crespo and Rene Drucker-Colin

Glycine Reuptake Inhibition as a New Therapeutic Approach in Schizophrenia: Focus on the Glycine Transporter 1 (GlyT1)

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 7
Page: 1311-1320
Authors: Pierre Chue

Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? - A Systematic Review of Structural and Functional Brain Abnormalities

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 3
Page: 467-481
Authors: R. Smieskova, J. Marmy, A. Schmidt, K. Bendfeldt, A. Riecher-Rossler, M. Walter, U. E. Lang and S. Borgwardt

Parkinson's Disease Management. Part II- Discovery of MAO-B Inhibitors Based on Nitrogen Heterocycles and Analogues

Journal: Current Topics in Medicinal Chemistry
Volume: 12,Issue: 20
Page: 2116-2130
Authors: Joana Reis, Igor Encarnacao, Alexandra Gaspar, Aliuska Morales, Nuno Milhazes and Fernanda Borges

Melatonin and Pineal Gland Peptides Are Able to Correct the Impairment of Reproductive Cycles in Rats

Journal: Current Aging Science
Volume: 5,Issue: 3
Page: 178-185
Authors: Alexander Arutjunyan, Ljudmila Kozina, Yulia Milyutina, Andrew Korenevsky, Michael Stepanov and Vladimir Arutyunov

Effect of Withania somnifera Supplementation on Rotenone-Induced Oxidative Damage in Cerebellum and Striatum of the Male Mice Brain

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 43-56
Authors: Mallaya Jayawanth Manjunath and Muralidhara

Modulation of Monoaminergic Transporters by Choline-Containing Phospholipids in Rat Brain

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 1
Page: 94-103
Authors: Seyed Khosrow Tayebati, Daniele Tomassoni, Innocent Ejike Nwankwo, Antonio Di Stefano, Piera Sozio, Laura Serafina Cerasa and Francesco Amenta

Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression

Journal: Current Molecular Medicine
Volume: 13,Issue: 4
Page: 555-571
Authors: M. Ruscica, M. Arvigo, L. Steffani, D. Ferone and P. Magni

Effects of Novel Monoamine Oxidases and Cholinesterases Targeting Compounds on Brain Neurotransmitters and Behavior in Rat Model of Vascular Dementia

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 2
Page: 161-171
Authors: Anna Stasiak, Miroslaw Mussur, Mercedes Unzeta, Abdelouahid Samadi, Jose L. Marco-Contelles and W. Agnieszka Fogel

Domperidone in Parkinson’s Disease: A Perilous Arrhythmogenic or the Gold Standard?

Journal: Current Drug Safety
Volume: 8,Issue: 1
Page: 63-68
Authors: Unax Lertxundi, Saioa Domingo- Echaburu, Amaia Soraluce, Montserrat Garcia, Borja Ruiz- Osante and Carmelo Aguirre

The Control of Male Sexual Responses

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 24
Page: 4341-4356
Authors: Frederique Courtois, Serge Carrier, Kathleen Charvier, Pierre A. Guertin and Nicolas Morel Journel

Strength and Weaknesses of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Possible Detection of Overlaps with Frailty Process

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 4
Page: 538-546
Authors: Alessandro Stefani, Enrica Olivola, Mario Stampanoni Bassi, Valerio Pisani, Paola Imbriani, Antonio Pisani and Mariangela Pierantozzi

Cannabinoids and Schizophrenia: Therapeutic Prospects

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 13
Page: 2194-2204
Authors: P.J. Robson, G.W. Guy and V. Di Marzo

Dangerous Liaisons between Beta-Amyloid and Cholinergic Neurotransmission

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 15
Page: 2525-2538
Authors: Stefano Govoni, Elisa Mura, Stefania Preda, Marco Racchi, Cristina Lanni, Massimo Grilli, Stefania Zappettini, Alessia Salamone, Guendalina Olivero, Anna Pittaluga and Mario Marchi

Addictions and Stress: Clues for Cocaine Pharmacotherapies

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 40
Page: 7065-7080
Authors: R. Picetti, S. D. Schlussman, Y. Zhou, B. Ray, E. Ducat, V. Yuferov and M. J. Kreek

The Monoaminergic Tripartite Synapse: A Putative Target for Currently Available Antidepressant Drugs

Journal: Current Drug Targets
Volume: 14,Issue: 11
Page: 1277-1294
Authors: Gaël Quesseveur, Alain M. Gardier and Bruno P. Guiard

Exercise Addiction- Diagnosis, Bio-Psychological Mechanisms and Treatment Issues

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 25
Page: 4062-4069
Authors: Aviv Weinstein and Yitzhak Weinstein

Pharmacogenetic Analysis of SNPs in Genes Involved in the Pharmacokinetics and Response to Lopinavir/Ritonavir Therapy

Journal: Current Drug Metabolism
Volume: 14,Issue: 7
Page: 729-737
Authors: E. López Aspiroz, S.E. Cabrera Figueroa, G.L. Porras Hurtado, G.L. Porras Hurtado, R. Cruz Guerrero, A. Domínguez-Gil Hurlé, A. Carracedo and The Tormes Team

Disorders of Consciousness and Pharmaceuticals that Act on Oxygen Based Amino Acid and Monoamine Neurotransmitter Pathways of the Brain

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 26
Page: 4140-4153
Authors: Ralf Clauss

Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives

Journal: Current Drug Targets
Volume: 15,Issue: 2
Page: 210-253
Authors: Arunachalam Muthuraman, Nirmal Singh, Amteshwar Singh Jaggi and Muthusamy Ramesh

Chronic Paroxetine Treatment: Effects on Other Non-Serotonergic Neurotransmitter Systems

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 8
Page: 1226-1232
Authors: Paola Ballesteros-Zebadua, Joaquin Manjarrez-Marmolejo and Javier Franco-Perez

A Review of Monoamine Transporter-Ligand Interactions

Journal: Current Computer Aided-Drug Design
Volume: 9,Issue: 4
Page: 556-568
Authors: Kalyan Immadisetty and Jeffry D. Madura

Update on the Pharmacological Treatment of Pathological Gambling

Journal: Current Psychopharmacology
Volume: 2,Issue: 3
Page: 204-211
Authors: Scott A. Bullock and Marc N. Potenza

Citrus Peel Extract Attenuates Acute Cyanide Poisoning-Induced Seizures and Oxidative Stress in Rats

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 4
Page: 638-646
Authors: Ahmed E. Abdel Moneim

Neurochemical Substrates of MDMA Reward: Effects of the Inhibition of Serotonin Reuptake on the Acquisition and Reinstatement of MDMA-induced CPP

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 40
Page: 7050-7064
Authors: C. Roger-Sánchez, M. A. Aguilar, C. Manzanedo, J. Miñarro and M. Rodríguez-Arias

Modulation of 3,4-Methylenedioxymethamphetamine Effects by Endocannabinoid System

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 40
Page: 7081-7091
Authors: Olga Valverde and Marta Rodríguez-Árias

Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease

Journal: Current Genomics
Volume: 14,Issue: 8
Page: 502-517
Authors: Anna Oczkowska, Wojciech Kozubski, Margarita Lianeri and Jolanta Dorszewska

Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson’s Disease

Journal: Current Genomics
Volume: 14,Issue: 8
Page: 518-533
Authors: Jolanta Dorszewska, Michal Prendecki, Anna Oczkowska, Agata Rozycka, Margarita Lianeri and Wojciech Kozubski

Assessing and Treating Cognitive Impairment in Schizophrenia: Current and Future

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 32
Page: 5127-5138
Authors: Chun-Yuan Lin, Guochuan E. Tsai and Hsien-Yuan Lane

Pharmacological Strategies for the Prevention of Acute Kidney Injury Following Cardiac Surgery: An Overview of Systematic Reviews

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 34
Page: 5484-5488
Authors: Nishith N. Patel and Gianni D. Angelini

Genomic and Pharmacogenomic Biomarkers of Parkinson’s Disease

Journal: Current Drug Metabolism
Volume: 15,Issue: 2
Page: 129-181
Authors: Hortensia Alonso-Navarro, Felix Javier Jimenez-Jimenez, Elena Garcia-Martin and Jose A.G. Agundez

SHP-2 Regulates Growth Factor Dependent Vascular Signalling and Function

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 14,Issue: 6
Page: 471-483
Authors: Hanna Mannell and Florian Krotz

Animal Models for Parkinson's Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 9
Page: 1580-1594
Authors: Dilip A. Patil, Vishal A. Patil, Sanjay B. Bari, Sanjay J. Surana and Pravin O. Patil

Computational Study of Human Tyrosine Hydroxylase Mutants to Uphold [4-(Propan-2-yl) Phenyl]Carbamic Acid as a Potential Inhibitor

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 7
Page: 1169-1174
Authors: Muhammad S. Nawaz, Zahida Parveen, Liyong Wang, Sajid Rashid, Muhammad Q. Fatmi and Mohammad A. Kamal

Dopaminergic Neuron-Like Cells Derived from Bone Marrow Mesenchymal Stem Cells by Lmx1α and Neurturin Overexpression for Autologous Cytotherapy in Hemiparkinsonian Rhesus Monkeys

Journal: Current Stem Cell Research & Therapy
Volume: 10,Issue: 2
Page: 109-120
Authors: Wan-Pu Wang, Zhan-Long He, Shuai-Yao Lu, Min Yan, Yan Zhou, Tian-Hong Xie, Na Yin, Dong-Hong Tang, Hong-Jun Li and Mao-Sheng Sun

Long-term Potentiation at Spinal C-fiber Synapses: A Target for Pathological Pain

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 7
Page: 895-905
Authors: Xian-Guo Liu and Li-Jun Zhou

Liver Growth Factor as a Tissue Regenerating Factor in Neurodegenerative Diseases

Journal: Recent Patents on CNS Drug Discovery
Volume: 9,Issue: 3
Page: 173-180
Authors: Rafael Gonzalo-Gobernado, Lucia Calatrava-Ferreras, Juan Perucho, Diana Reimers, MarIa J. Casarejos, Antonio S. Herranz, Adriano Jimenez-Escrig, Juan J. Diaz-Gil and Eulalia Bazan

Pharmacology of Ultrasonic Vocalizations in adult Rats: Significance, Call Classification and Neural Substrate

Journal: Current Neuropharmacology
Volume: 13,Issue: 2
Page: 180-192
Authors: Stefan M. Brudzynski

Ca2+-Myristoyl Switch in Neuronal Calcium Sensor-1: A Role of C-Terminal Segment

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 4
Page: 437-451
Authors: Viktoriia E. Baksheeva, Aliya A. Nazipova, Dmitry V. Zinchenko, Marina V. Serebryakova, Ivan I. Senin, Sergei E. Permyakov, Pavel P. Philippov, Yi Li, Andrey A. Zamyatnin, Evgeni Y. Zernii and Gjumrakch Aliev


Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson`s Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 6
Page: 777-785
Authors: Youssef Sari and Ashraf Khalil

The Role of N-Methyl-D-Aspartate Receptor - Mediated Neurotransmission in Attention Deficit (Hyperactivity) Disorder (ADHD/ADD)

Journal: Current Psychopharmacology
Volume: 3,Issue: 3
Page: 184-194
Authors: Andrea R. Durrant and Uriel Heresco-Levy

Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 26
Page: 3771-3787
Authors: Philipp Singer, Sylvain Dubroqua and Benjamin K. Yee

Intramolecular Processes and Their Applications in Prodrugs Approaches- Experimental and Computational Studies

Journal: Current Organic Chemistry
Volume: 20,Issue: 3
Page: 289-315
Authors: Rafik Karaman, Salma Jumaa, Heba Awwadallah, Samya Salah, Yahya Khawaja and Donia Karaman

Lower Frequency of co-Morbid Medical Disorders Related to Poor Impulse Control in Parkinson’s than Alzheimer’s Disease

Journal: Current Aging Science
Volume: 9,Issue: 1
Page: 57-60
Authors: Erin K. Saito, Natalie Diaz, Julia Morrow, Julia Chung and Aaron McMurtray

Inflammatory Process in Alzheimer’s and Parkinson's Diseases: Central Role of Cytokines

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 5
Page: 541-548
Authors: Qamre Alam, Mohammad Zubair Alam, Gohar Mushtaq, Ghazi A. Damanhouri, Mahmood Rasool, Mohammad Amjad Kamal and Absarul Haque

The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 8
Page: 963-977
Authors: Gerwyn Morris, André F. Carvalho, George Anderson, Piotr Galecki and Michael Maes

Global Expression Studies of Schizophrenic Brain: A Meta-Analysis Study Linking Neurological Immune System with Psychological Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15,Issue: 4
Page: 477-488
Authors: Sajjad Karim, Mohammad A. Kamal, Zafar Iqbal, Shakeel A. Ansari, Mahmood Rasool, Mohammed H. Al-Qahtani, Gazi Damanhouri and Zeenat Mirza

Personalized Treatment of Obsessive-Compulsive Disorder: Radiology, EEG, Pharmacogenetics and Biochemistry

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 13,Issue: 2
Page: 69-83
Authors: Oguz Tan

Synthetic and Natural Monoamine Oxidase Inhibitors as Potential Lead Compounds for Effective Therapeutics

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 81-97
Authors: Ashish Pathak, Amit K. Srivastava, Pradeep K. Singour and Panchanan Gouda

Ether and Carbamate Derivatives of 3-quinuclidinol and 3- hydroxymethylquinuclidine: Synthesis and Evaluation as Nicotinic Ligands

Journal: Medicinal Chemistry
Volume: 12,Issue: 6
Page: 574-584
Authors: Sivakumar Annadurai, Min Zhang, Jerome L. Gabriel, Merouane Bencheriff and Daniel J. Canney

Current Trends on Antipsychotics: Focus on Asenapine

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 21
Page: 2204-2216
Authors: Donatella Marazziti, Armando Piccinni, Stefano Baroni, Francesco Mungai, Silvio Presta, Federico Mucci and Liliana Dell';Osso

Thiophene Scaffold as Prospective Central Nervous System Agent: A Review

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 158-164
Authors: Aakash Deep, Balasubramanian Narasimhan, Swati Aggarwal, Dhirender Kaushik and Arun K. Sharma

An Overview on the Role of α -Synuclein in Experimental Models of Parkinson’s Disease from Pathogenesis to Therapeutics

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15,Issue: 10
Page: 1240-1252
Authors: Hayate Javed, Mohammad Amjad Kamal and Shreesh Ojha

Multiple Faceted Roles of Cocaine in Potentiation of HAND

Journal: Current HIV Research
Volume: 14,Issue: 5
Page: 412-416
Authors: Yu Cai, Lu Yang, Shannon Callen and Shilpa Buch

Molecular Effects of L-dopa Therapy in Parkinson’s Disease

Journal: Current Genomics
Volume: 15,Issue: 1
Page: 11-17
Authors: Jolanta Dorszewska, Michal Prendecki, Margarita Lianeri and Wojciech Kozubski

The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 33
Page: 5144-5162
Authors: Domenico De Berardis, Laura Orsolini, Felice Iasevoli, Emiliano Prinzivalli, Andrea de Bartolomeis, Nicola Serroni, Monica Mazza, Alessandro Valchera, Michele Fornaro, Roberta Vecchiotti, Alessandro Carano, Gianna Sepede, Federica Vellante, Ilaria Matarazzo, Maurizio Pompili, Giampaolo Perna, Chiara Conti, Cristina Segura-García, Giovanni Martinotti and Massimo Di Giannantonio

Nose to Brain Delivery of Nanoformulations for Neurotherapeutics in Parkinson’s Disease: Defining the Preclinical, Clinical and Toxicity Issues

Journal: Current Drug Delivery
Volume: 13,Issue: 8
Page: 1205-1221
Authors: Kamla Pathak and Nida Akhtar

Synthesis and Antinociception Activities of Some Novel Derivatives of Phencyclidine with Substituted Aminobenzothiazoles

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17,Issue: 1
Page: 78-84
Authors: Abbas Ahmadi, Mohsen Khalili, Behrooz Mirza, Mojtaba Mohammadi-Diz, Farnaz Azami-Lorestani, Parisa Ghaderi and Babak Nahri-Niknafs

Use of Dopaminergic Agents in the Treatment-Resistant Depression

Journal: Current Psychopharmacology
Volume: 4,Issue: 2
Page: 70-75
Authors: Lorena Rodríguez-Bores, Mónica Flores-Ramos and Rafael Campuzano

Overview of Short-Term and Long-Term Safety of Brexpiprazole in Patients with Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Journal: Current Psychiatry Reviews
Volume: 12,Issue: 3
Page: 278-290
Authors: James C. Nelson, Peter Zhang, Aleksandar Skuban, Mary Hobart, Catherine Weiss, Emmanuelle Weiller and Michael E. Thase

Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder

Journal: Current Neuropharmacology
Volume: 15,Issue: 1
Page: 57-70
Authors: Brittany A. Jaso, Mark J. Niciu, Nicolas D. Iadarola, Niall Lally, Erica M. Richards, Minkyung Park, Elizabeth D. Ballard, Allison C. Nugent, Rodrigo Machado-Vieira and Carlos A. Zarate

Sexual Side Effects of Psychotropics; Implications for Clinical Practice

Journal: Current Psychopharmacology
Volume: 4,Issue: 1
Page: 4-9
Authors: Vijender Singh and Bhavuk Garg

Natural Products Combating Neurodegeneration: Parkinson’s Disease

Journal: Current Drug Metabolism
Volume: 18,Issue: 1
Page: 50-61
Authors: Md. Solayman, Md. Asiful Islam, Fahmida Alam, Md. Ibrahim Khalil, Mohammad Amjad Kamal and Siew Hua Gan

Insilico Analysis of Post-Translational Modifications in DRD2 Receptor Protein in Schizophrenic Patients

Journal: Current Proteomics
Volume: 14,Issue: 1
Page: 53-57
Authors: Afshan Zeeshan Wasti, Nikhat Ahmed, Hajira Karim, Amna Ahmed and Ayesha Khan

Intramuscular Route of Administration Increases Potency in Eliciting Cocaine-Induced Behavioral Sensitization

Journal: Current Psychopharmacology
Volume: 6,Issue: 1
Page: 36-42
Authors: Beth A. Rice, Raza Tariq and Chana K. Akins

Neuromodulation of Spinal Locomotor Networks in Rodents

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 12
Page: 1741-1752
Authors: Manuel Diaz-Ríos, Pierre A. Guertin and Marla Rivera-Oliver

Pharmacology of Appetite Suppression: Implication for the Treatment of Obesity

Journal: Current Drug Targets
Volume: 2,Issue: 4
Page: 353-370
Authors: Jason C. G. Halford

The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinsons disease

Journal: Current Pharmaceutical Design
Volume: 17,Issue: 5
Page: 489-507
Authors: Rui D. S. Prediger, Aderbal S. Aguiar, Eduardo L. G. Moreira, Filipe C. Matheus, Adalberto A. Castro, Roger Walz, Andreza F. De Bem, Alexandra Latini, Carla I. Tasca, Marcelo Farina and Rita Raisman-Vozari

1-Cyclohexylpiperazine and 3,3-Dimethylpiperidine Derivatives as Sigma-1 (σ1) and Sigma-2 (σ2) Receptor Ligands: A Review

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 9,Issue: 3
Page: 205-219
Authors: Francesco Berardi, Carmen Abate, Savina Ferorelli, Nicola Antonio Colabufo and Roberto Perrone

Novel Insight into Cholinergic Factors Associated with Schizophrenia and Autoimmunity

Journal: Current Immunology Reviews
Volume: 6,Issue: 4
Page: 273-286
Authors: Leonor Sterin-Borda and Enri Borda

The Psychopharmacology of Appetite: Targets for Potential Anti-Obesity Agents

Journal: Current Medicinal Chemistry-Central Nervous System Agents
Volume: 3,Issue: 4
Page: 283-310
Authors: Jason C.G. Halford, Gillian D. Cooper, Terence M. Dovey, Yuko Ishii, John Rodgers and John E. Blundell

Editorial: Current Pro-Cognitive Therapeutic Strategies for Improved Pharmacological Treatment in Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 31
Page: 5045-5045
Authors: Marie-Louise G. Wadenberg

Inquiries into the Biological Significance of Transmembrane AMPA Receptor Regulatory Protein (TARP) γ−8 Through Investigations of TARP γ−8 Null Mice§

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 5
Page: 612-626
Authors: Scott D. Gleason, Akihiko Kato, Hai H. Bui, Linda K. Thompson, Sabrina N. Valli, Patrick V. Stutz, Ming-Shang Kuo, Julie F. Falcone, Wesley H. Anderson, Xia Li and Jeffrey M. Witkin

Environmental and Pharmacological Modulation of Amphetamine- Induced 50-kHz Ultrasonic Vocalizations in Rats

Journal: Current Neuropharmacology
Volume: 13,Issue: 2
Page: 220-232
Authors: Henrike Rippberger, Marcel M. van Gaalen, Rainer K.W. Schwarting and Markus Wohr

When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic Efficacy

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 26
Page: 3788-3796
Authors: Gerard J. Marek

Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer’s Disease

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 14
Page: 2064-2071
Authors: Felix-Martin Werner and Rafael Covenas

Review of Antibiotic and Non-Antibiotic Properties of Beta-lactam Molecules

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 3-14
Authors: Ochoa-Aguilar Abraham, Ventura-Martinez Rosa, Sotomayor-Sobrino Marco Antonio, Gómez Claudia and Morales-Espinosa María del Rosario

Oxidative Stress in the Molecular Mechanism of Pathogenesis at Different Diseased States of Organism in Clinics and Experiment

Journal: Current Drug Target -Inflammation & Allergy
Volume: 4,Issue: 1
Page: 85-98
Authors: Konstantin G. Karageuzyan

Recent Strategies for Potentiation and Facilitation of Antidepressant Treatment: Introduction

Journal: Current Drug Targets
Volume: 7,Issue: 2
Page: 137-137
Authors: Bernard Lerer

Editorial (Thematic Issue: Understanding the Role of Heteroreceptor Complexes in the Central Nervous System)

Journal: Current Protein & Peptide Science
Volume: 15,Issue: 7
Page: 647-647
Authors: Kjell Fuxe, Dasiel Borroto-Escuela, Gilberto Fisone, Luigi F. Agnati and Sergio Tanganelli

Molecule of the Month

Journal: Current Topics in Medicinal Chemistry
Volume: 8,Issue: 6
Page: 531-531
Authors: Craig W. Lindsley

Conference Report (42nd Annual Meeting of the Italian Society of Neurology, 22-25 October 2011, Turin, Italy)

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11,Issue: 1
Page: 2-3
Authors: Stephen D. Skaper

Conference Report: 9th International Summer School of Neurology

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13,Issue: 7
Page: 1121-1124
Authors: Stephen D. Skaper

Results 1 - 707 of 707